Source document: https://docs-lawep.s3.us-east-2.amazonaws.com/1698751337907.pdf (New Zealand)
Reprint as at 1 April 2008 Misuse of Drugs Act 1975 Public Act Date of assent 1975 No 116 10 October 1975 Contents Title Short Title and commencement Interpretation Act to bind the Crown Classiﬁcation of drugs Amendment of schedules that identify controlled drugs and precursor substances, and set amount, level, or quantity at and over which controlled drugs are presumed to be for supply Procedure for bringing Order in Council made under section 4(1) or (1B) into force Matters to which Minister must have regard before recommending Order in Council under section 4(1) or (1B) Advisory and technical committees 1 2 3 3A 4 4A 4B 5 Page 4 4 4 9 9 9 12 12 14 Note Changes authorised by section 17C of the Acts and Regulations Publication Act 1989 have been made in this eprint.
A general outline of these changes is set out in the notes at the end of this eprint, together with other explanatory material about this eprint.
This Act is administered in the Ministry of Health 1 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 5AA Expert Advisory Committee on Drugs 5A 5B Approved laboratories Functions of Minister Dealing with controlled drugs Possession and use of controlled drugs Exemptions from sections 6 and 7 Cultivation of prohibited plants Aiding offences against corresponding law of another country Theft, etc, of controlled drugs Use of premises or vehicle Equipment, material, and substances used in production or cultivation of controlled drugs 11 12 12A 12AB Offence to knowingly import or export precursor substances for unlawful use 12AC Offence to import or export precursor substance without reasonable excuse Laundering proceeds of drug offences Commission of offences outside New Zealand Miscellaneous offences Licences False statements Obstruction of ofﬁcers Liability of principal for acts of agent, etc Search and seizure Internal search of person under arrest Power to demand production of records and to inspect stocks of controlled drugs Statements regarding drug dependent persons Power of Court to restrict publication of name of controlled drug Powers of Minister to prohibit importation, etc, of controlled drugs Powers of Minister to prohibit prescribing, etc Treatment of people dependent on controlled drugs Restrictions on supply to particular persons Arrest by Customs Ofﬁcers General penalty Legal proceedings Consent of Attorney­General required in proceedings under section 12C 12B 12C 18A 26 27 28 28A Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 29 29A 29B 29C 30 31 32 33 34 34A 35 35A 35B 35C 35D 36 37 38 39 40 41 Mistake as to nature of controlled drug or precursor substance Issue of usable quantity Special provisions where offence relating to cannabis preparations alleged Special provisions where offence relating to controlled drug analogues alleged Burden
 of proof Evidence of analysis Forfeiture Notiﬁcation of conviction of medical practitioners, etc Protection of persons acting under authority of Act Protection of Police ofﬁcers Crimes deemed to be included in extradition treaties Further provision on crimes to be treated as included in extradition treaties Surrender of offenders [Repealed] Restrictions on surrender of offenders Evidence Application of Customs and Excise Act 1996 Regulations Effect on Poisons Act 1960 [Repealed] Repeals Revocations Application to Niue 689A Misuse of Drugs Act in force in Niue Schedule 1 Class A controlled drugs Schedule 2 Class B controlled drugs Schedule 3 Class C controlled drugs Schedule 4 Precursor Substances Schedule 5 Amount, level, or quantity at and over which controlled drugs are presumed to be for supply 60 60 61 61 62 62 65 67 67 68 68 69 71 71 71 72 73 76 76 76 77 77 78 81 92 105 107 3 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 An Act to consolidate and amend the Narcotics Act 1965 and to make further provision for the prevention of misuse of drugs BE IT ENACTED by the General Assembly of New Zealand in Parliament assembled, and by the authority of the same, as follows: Short Title and commencement This Act may be cited as the Misuse of Drugs Act 1975.
This Act shall come into force on a date to be appointed for the commencement thereof by the Governor­General by Order in Council.

this deﬁnition was inserted, as from 1 July 1992, by Interpretation In this Act, unless the context otherwise requires,— Approved laboratory means a laboratory for the time being approved under section 5A of this Act Approved laboratory: section 2 Misuse of Drugs Amendment Act 1992 (1992 No 49).
Carrier includes every person engaged in carrying goods (including mail) for hire or reward by any means, and whether by land, water, or air Carrier: this deﬁnition was amended, as from 1 April 1998, by section 62(1) Postal Services Act 1998 (1998 No 2) by inserting the words “(including mail)”.

See clause 2 Postal Services Act Commencement Order 1998 (SR 1998/49).
Class A controlled drug means the controlled drugs speciﬁed or described in Schedule 1 to this Act Class A controlled drug: this deﬁnition was inserted, as from 2 September 1996, by section 2(2) Misuse of Drugs Amendment Act 1996 (1996 No 133).

Class B controlled drug means the controlled drugs speciﬁed or described in Schedule 2 to this Act Class B controlled drug: this deﬁnition was inserted, as from 2 September 1996, by section 2(2) Misuse of Drugs Amendment Act 1996 (1996 No 133).
Class C controlled drug means the controlled drugs speciﬁed or described in Schedule 3 to this Act ; and includes any controlled drug analogue Class C controlled drug: this deﬁnition was inserted, as from 2 September 1996, by section 2(2) Misuse of Drugs Amendment Act 1996 (1996 No 133).
1 (1) (2) 2 (1) 4 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 2 Controlled drug means any substance, preparation, mixture, or article speciﬁed or described in Schedule 1, Schedule 2, or Schedule 3 to this Act ; and includes any controlled drug analogue Controlled drug: this deﬁnition was substituted, as from 2 September 1996, by section 2(1) Misuse of Drugs Amendment Act 1996 (1996 No 133).
Controlled drug analogue means any substance, such as the substances speciﬁed or described in Part 7 of Schedule 3 to this Act, that has a structure substantially similar to that of any controlled drug; but does not include— (a) Any substance speciﬁed or described in Schedule 1 or Schedule 2 or Parts 1 to 6 of Schedule 3 to this Act ; or (b) Any pharmacy­only medicine or prescription medicine or restricted medicine within the meaning of the Medicines Act 1981: Controlled drug analogue: this deﬁnition was inserted, as from 13 January 1988, by section 2(1) Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193).
Cultivate includes sow or plant; and cultivation has a corresponding meaning dentist means a health practitioner who is, or is deemed to be, registered with the Dental Council established by section 114(2) of the Health Practitioners Competence Assurance Act 2003 as a practitioner of the profession of dentistry Dentist: this deﬁnition was amended, as from 1 January 1989, by substituting the Dental Act 1988 (1988 No 150) for the repealed Dental Act 1963.
Dentist: this deﬁnition was substituted, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48).

See sections 178 to 227 of that Act as to the transitional provisions.
Dependent means being in a state of periodic or chronic intoxication, produced by the repeated consumption, smoking, or other use of a controlled drug detrimental to the person in relation to whom the word is used, and involving a compulsive desire to continue consuming, smoking, or otherwise using the drug or a tendency to increase the dose of the drug; and dependency has a corresponding meaning Designated prescriber has the same meaning as it has in section 2(1) of the Medicines Act 1981 Designated prescriber: this deﬁnition was inserted, as from 15 October 1999, by section 16 Medicines Amendment Act 1999 (1999 No 117).
5 s 2 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 Medical Ofﬁcer of Health means a Medical Ofﬁcer of Health within the meaning of the Health Act 1956 ; and includes the ofﬁcers referred to in section 22 of that Act medical practitioner means a health practitioner who is, or is deemed to be, registered with the Medical Council of New Zealand continued by section 114(1)(a) of the Health Practitioners Competence Assurance Act 2003 as a practitioner of the profession of medicine Medical practitioner: substituted, as from 1 July 1996, by section 143(1) Medical Practitioners Act 1995 (1995 No 95).
See clause 2 Medical Practitioners Act Commencement Order 1996 (SR 1996/162).

medical practitioner: this deﬁnition was substituted, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48).

See sections 178 to 227 of that Act as to the transitional provisions.
midwife means a health practitioner who is, or is deemed to be, registered with the Midwifery Council established by section 114(3) of the Health Practitioners Competence Assurance Act 2003 as a practitioner of the profession of midwifery midwife: this deﬁnition was inserted, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48).

See sections 178 to 227 of that Act as to the transitional provisions.
Minister means the Minister of Health pharmacist means a health practitioner who is, or is deemed to be, registered with the Pharmacy Council established by section 114(5) of the Health Practitioners Competence Assurance Act 2003 as a practitioner of the profession of pharmacy Pharmacist: paragraph (b) of this deﬁnition was substituted, as from 1 October 2002 by section 58(1) Health and Disability Services (Safety) Act 2001 (2001 No 93).

See section 11 of that Act for transitional provisions.
this deﬁnition was substituted, as from 18 September 2004, by pharmacist: section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48).

See sections 178 to 227 of that Act as to the transitional provisions.

Precursor substance means any substance speciﬁed or described in Part 1 or Part 2 or Part 3 of Schedule 4 Precursor substance: section 2 Misuse of Drugs Amendment Act 1998 (1998 No 14).
this deﬁnition was inserted, as from 12 May 1998, by Precursor substance: this deﬁnition was amended, as from 22 June 2005, by section 3(1) Misuse of Drugs Amendment Act 2005 (2005 No 81) by inserting the words “or Part 3” after the words “or Part 2”.
6 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 2 and production has a Produce includes compound; corresponding meaning Prohibited plant means— (a) (b) Any plant of the species Papaver somniferum: (c) Any plant of the genus Cannabis: Erythroxylon coca and Erythroxylon novagranatense (syn E truxillense ) and every other species of the genus Erythroxylon from which a controlled drug can be produced: (d) Any plant of the species Lophophora williamsii or (e) (f) Lophophora lewinii: the genera Conocybe, Panaeolus, Any fungus of or Psilocybe from which a controlled drug can be produced or which contains a controlled drug: Any other plant which is declared to be a prohibited plant by regulations made under this Act: Prohibited plant: paragraph (e) of this deﬁnition was substituted, as from 13 January 1988, by section 2(2) Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193).
registered health professional means a health practitioner who is, or is deemed to be, registered with an authority the Health established or continued by section 114 of a Practitioners Competence Assurance Act 2003 as practitioner of a particular health profession.

registered health professional: this deﬁnition was inserted, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48).

See sections 178 to 227 of that Act as to the transitional provisions.
Registered midwife[Repealed] Registered midwife: this deﬁnition was inserted, as from 28 August 1990, by section 13 Nurses Amendment Act 1990 (1990 No 107).

Registered midwife: this deﬁnition was repealed, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48).

See sections 178 to 227 of that Act as to the transitional provisions.
[Repealed] Standing order has the same meaning as it has in section 2(1) of the Medicines Act 1981 Standing order: this deﬁnition was inserted, as from 15 October 1999, by section 16 Medicines Amendment Act 1999 (1999 No 117).
Supply includes distribute, give, and sell 7 s 2 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 veterinarian means a veterinarian or a specialist within the meaning of section 4 of the Veterinarians Act 2005. veterinarian: this deﬁnition was inserted, as from 22 December 2005, by section 105 Veterinarians Act 2005 (2005 No 126).

Veterinary surgeon[Repealed] Veterinary surgeon: this deﬁnition was repealed, as from 22 December 2005, by section 105 Veterinarians Act 2005 (2005 No 126).
[Repealed] Vienna Convention means the United Nations Convention Against Illicit Trafﬁc in Narcotic Drugs and Psychotropic Substances adopted in Vienna on 19 December 1988 Vienna Convention: section 2 Misuse of Drugs Amendment Act 1998 (1998 No 14).
this deﬁnition was inserted, as from 12 May 1998, by (3) (2) (1A) Any reference in this Act to an amount, level, or quantity at and over which a controlled drug is presumed to be for supply is a reference to the amount, level, or quantity speciﬁed in Schedule 5.

For the purposes of this Act, the things which a person has in his possession include any thing subject to his control which is in the custody of another.
In calculating for the purposes of this Act the percentage of any substance present in a preparation, the percentage in the case of a liquid preparation shall, unless otherwise prescribed, be calculated on the basis that a preparation containing one part percent of any substance means a preparation in which one gram of the substance, if a solid, or one millilitre of the substance, if a liquid, is contained in every hundred millilitres of the preparation and so in proportion for any greater or less percentage.
In calculating for the purposes of this Act the percentage of morphine present in a preparation it shall be calculated as in respect of anhydrous morphine.

For the purposes of this Act, a salt of any controlled drug shall be deemed to contain that drug.
Compare: 1965 No 45 s 2 ; SR 1966/82, regs 2, 2A, 15(1), 25A(1) ; SR 1967/173, reg 2 ; SR 1973/100, reg 7 ; Misuse of Drugs Act 1971, s 37(3) (UK) (5) (4) Subsection (1A) was inserted, as from 22 June 2005, by section 3(2) Misuse of Drugs Amendment Act 2005 (2005 No 81).

Subsection (5) was inserted, as from 13 January 1988, by section 2(3) Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193).
8 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 4 3 (1) (2) Act to bind the Crown Subject to subsection (2) of this section, this Act shall bind the Crown.
The Governor­General may, by Order in Council, exempt any instrument of the Executive Government of New Zealand, either absolutely or to such extent and subject to such conditions as may be speciﬁed in the Order in Council, from all or any of the provisions of this Act, and in that event, or to that extent and subject to compliance with any such conditions, this Act, or the provisions of this Act so speciﬁed, as the case may require, shall not bind the Crown in right of that instrument.
Compare: 1965 No 45 s 3 3A Classiﬁcation of drugs The classiﬁcation of a drug under this Act is based on the risk of harm the drug poses to individuals, or to society, by its misuse; and accordingly— (a) drugs that pose a very high risk of harm are classiﬁed as Class A drugs; and drugs that pose a high risk of harm are classiﬁed as Class B drugs; and drugs that pose a moderate risk of harm are classiﬁed as Class C drugs.
(b) (c) Section 3A was inserted, as from 15 November 2000, by section 3 Misuse of Drugs Amendment Act 2000 (2000 No 47).
4 (1) Amendment of schedules that identify controlled drugs and precursor substances, and set amount, level, or quantity at and over which controlled drugs are presumed to be for supply The Governor­General may, by Order in accordance with a recommendation of the Minister, amend Schedule 1, Schedule 2, Schedule 3, and Schedule 4, by doing any 1 or more of the following to any 1 or more of those schedules: (a) adding the name or description of any substance, prep­ aration, mixture, or article to a schedule; or in Council, 9 s 4 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 (b) removing the name or description of any substance, preparation, mixture, or article from a schedule; or (c) moving the name or description of any substance, prep­ aration, mixture, or article from 1 schedule, or Part or clause of a schedule, and inserting that name or descrip­ tion in another schedule, or Part or clause of a schedule.
(1A) An Order in Council may not be made under subsection (1) in relation to a controlled drug if the effect of the Order in Council is— (a) to remove the controlled drug from all of Schedules 1 to 3; or to move the controlled drug— (i) (ii) (iii) from Schedule 1 to Schedule 2 or Schedule 3; or from Schedule 2 to Schedule 3; or from Part 1 of Schedule 2 or of Schedule 3 to another part of the same schedule.
(b) (b) in Council, (1B) The Governor­General may, by Order in accordance with a recommendation of the Minister, amend Schedule 5 by doing any of the following: (a) altering the amount, level, or quantity at and over which any controlled drug is presumed to be for supply: adding any substance, preparation, mixture, or article that is to be classiﬁed as a controlled drug to clause 1 of Schedule 5 and the amount, level, or quantity at and over which it is presumed to be for supply.
(1C) An Order in Council may not be made under subsection (1B)(a) in relation to a controlled drug unless the name or description of the controlled drug is, at the same time, being moved from Schedule 1, 2, or 3, or from a part or clause of Schedule 1, 2, or 3 to another of those schedules, parts, or clauses.
(1D) An Order in Council may not be made under subsection (1B)(b) in relation to a substance, preparation, mixture, or article unless its name or description is, at the same time, being added to Schedule 1, 2, or 3.

(2) An Order in Council made under subsection (1) or subsection (1B) may not come into force except in accordance with a commencement order made under section 4A.
10 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 4 (b) (3) (4) Sections 5 to 10 of the Regulations (Disallowance) Act 1989 do not apply to any Order in Council made under subsection (1) or subsection (1B).
The Governor­General may, by Order in Council,— (a) amend the name or description of any substance, prepar­ ation, mixture, or article named or described in Sched­ ule 1, Schedule 2, Schedule 3, or Schedule 5, if the amendment is necessary for the purpose of rendering that name or description consistent with international scientiﬁc usage: update Schedule 1, Schedule 2, Schedule 3, or Schedule 5, if the update is necessary for the purpose of clarifying content or correcting drafting errors: add to, or remove from, Schedule 4 the name or descrip­ tion of any substance included in that schedule, if the amendment is necessary for the purpose of giving effect to any changes to the Annex to the Vienna Convention.
(5) No Order in Council may be made under paragraph (a) or paragraph (b) of subsection (4) if it has the effect of classifying, changing the classiﬁcation of, or declassifying any substance, preparation, mixture, or article.

Section 4 was substituted, as from 13 January 1983, by section 2 Misuse of Drugs Amendment Act 1982 (1982 No 151).

(c) Subsection (4) was inserted, as from 12 May 1998, by section 2 Misuse of Drugs Amendment Act 1998 (1998 No 14).
Section 4 was substituted, as from 15 November 2000, by section 4 Misuse of Drugs Amendment Act 2000 (2000 No 47).

The heading to section 4 was amended, as from 22 June 2005, by section 4(1) Misuse of Drugs Amendment Act 2005 (2005 No 81) by inserting the words “, and set amount, level, or quantity at and over which controlled drugs are presumed to be for supply”.

Subsections (1A) to (1D) were inserted, as from 22 June 2005, by section 4(2) Misuse of Drugs Amendment Act 2005 (2005 No 81).
Subsection (2) was amended, as from 22 June 2005, by section 4(3) Misuse of Drugs Amendment Act 2005 (2005 No 81) by inserting the words “or subsection (1B)” after the words “subsection (1)”.

Subsection (3) was amended, as from 22 June 2005, by section 4(4) Misuse of Drugs Amendment Act 2005 (2005 No 81) by inserting the words “or subsection (1B)”.
Subsection (4)(a) and (b) was amended, as from 22 June 2005, by section 4(5) Misuse of Drugs Amendment Act 2005 (2005 No 81) by substituting the words “Schedule 3, or Schedule 5” for the words “or Schedule 3”.
11 s 4A Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 4A Procedure for bringing Order in Council made under (1) (2) section 4(1) or (1B) into force Subject to subsection (2), the Governor­General may, by Order in Council, make a commencement order bringing any Order in Council made under section 4(1) or (1B) into force.

The commencement order may be made only after the Order in Council made under section 4(1) or (1B) has been approved by resolution of the House of Representatives.
(3) A resolution of the House of Representatives approving an Order in Council made under section 4(1) or (1B) may be made at any time after— (a) the date that is 28 days after the date on which notice that the Order in Council has been made is given in the Gazette; or if the Gazette notice is given during the period com­ mencing on 24 December in 1 year and ending on 15 January in the following year, 15 February of that fol­ lowing year.
(b) (4) An Order in Council made under section 4(1) or (1B) lapses if— (a) a motion to approve the Order in Council is defeated; or (b) No motion to approve the Order in Council is agreed to within 1 year of its date of making.

Section 4A was inserted, as from 16 October 1978, by section 2 Misuse of Drugs Amendment Act 1978 (1978 No 65).

Section 4A was substituted, as from 15 November 2000, by section 4 Misuse of Drugs Amendment Act 2000 (2000 No 47).
The heading to section 4A was amended, as from 22 June 2005, by section 5(1) Misuse of Drugs Amendment Act 2005 (2005 No 81) by inserting the expression “or (1B)” after the expression “section 4(1)”.

Subsections (1) to (4) were amended, as from 22 June 2005, by section 5(2) Misuse of Drugs Amendment Act 2005 (2005 No 81) by inserting the expression “or (1B)” after the expression “section 4(1)”.
4B Matters to which Minister must have regard before recommending Order in Council under section 4(1) or (1B) Before recommending to the Governor­General that an Order in Council be made under section 4(1), the Minister must, (1) 12 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 4B (2) (3) (4) (b) (c) (d) (e) (f) in respect of each substance, preparation, mixture, or article (drug) referred to in the proposed Order in Council,— (a) consult with, and consider any advice given by, the Ex­ pert Advisory Committee on Drugs established under section 5AA, about the drug; and have regard to the matters set out in subsection (2).
(b) The matters that the Minister must have regard to under subsection (1)(b), and on which the Expert Advisory Committee on Drugs must give advice, are— (a) the likelihood or evidence of drug abuse, including such matters as the prevalence of the drug, levels of con­ sumption, drug seizure trends, and the potential appeal to vulnerable populations; and the speciﬁc effects of the drug, including pharmacolog­ ical, psychoactive, and toxicological effects; and the risks, if any, to public health; and the therapeutic value of the drug, if any; and the potential for use of the drug to cause death; and the ability of the drug to create physical or psycho­ logical dependence; and the international classiﬁcation and experience of the drug in other jurisdictions; and any other matters that the Minister considers relevant.
(h) Before recommending to the Governor­General that an Order in Council be made under section 4(1B), the Minister must, in relation to the amount, level, or quantity at and over which any controlled drug is to be presumed to be for supply in the proposed Order in Council,— (a) consult with, and consider any advice given by, the Ex­ pert Advisory Committee on Drugs established under section 5AA, about the amount, level, or quantity at and over which a controlled drug might be presumed to be for supply; and have regard to the matters in subsection (4).
(b) The matters that the Minister must have regard to under subsection (3)(b), and on which the Expert Advisory Committee on Drugs may give advice, are— (a) the amount of the drug that could reasonably be pos­ sessed for personal use, including, without limitation, (g) 13 s 5 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 (b) levels of consumption, the ability of the drug to create physical or psychological dependence, and the speciﬁc effects of the drug; and the amount, level, or quantity at and over which the drug is presumed to be for supply in other jurisdictions; and (c) any other matters that the Minister considers relevant.
Section 4B was inserted, as from 15 November 2000, by section 4 Misuse of Drugs Amendment Act 2000 (2000 No 47).

The heading to section 4B was amended, as from 22 June 2005, by section 6(1) Misuse of Drugs Amendment Act 2005 (2005 No 81) by inserting the expression “or (1B)” after the expression “section 4(1)”.
Subsection (2) was amended, as from 22 June 2005, by section 6(2) Misuse of Drugs Amendment Act 2005 (2005 No 81) by inserting the words “under subsection (1)(b)” after the words “must have regard to”.

Subsections (3) and (4) were inserted, as from 22 June 2005, by section 6(3) Misuse of Drugs Amendment Act 2005 (2005 No 81).
5 (1) (2) (3) Advisory and technical committees The Minister may from time to time appoint such advisory or technical committees as he thinks ﬁt to advise him for any of the purposes of this Act, and may from time to time determine the functions of any such committee.
There may be paid out of money appropriated by Parliament for the purpose to the members of any committee appointed under this section remuneration by way of fees, salary, or allowances and travelling allowances and expenses in accordance with the Fees and Travelling Allowances Act 1951, and the provisions of that Act shall apply accordingly as if the committee were a statutory Board within the meaning of that Act.
Subject to the provisions of this Act and of any regulations made under this Act, every such committee may regulate its own procedure.

5AA Expert Advisory Committee on Drugs (1) The Minister must establish an Expert Advisory Committee on Drugs to advise the Minister on drug classiﬁcation matters.
The functions of the Committee are— (2) 14 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 5AA (a) (b) to carry out medical and scientiﬁc evaluations of con­ trolled drugs, and any other narcotic or psychotropic substances, preparations, mixtures, or articles; and to make recommendations to the Minister about— (i) whether and how controlled drugs or other sub­ stances, preparations, mixtures, or articles should be classiﬁed; and the amount, level, or quantity at and over which any substance, preparation, mixture, or article that is a controlled drug (or is proposed to be clas­ siﬁed as a controlled drug), and that is to be spe­ ciﬁed or described in clause 1 of Schedule 5, is to be presumed to be for supply; and the level at and over which controlled drugs to which clause 2 of Schedule 5 applies are pre­ sumed to be for supply; and (ii) (iii) (c) to increase public awareness of the Committee’s work, by (for instance) the timely release of papers, reports, and recommendations.
The Committee must comprise— (a) (3) pharmacology: toxicology: drug and alcohol treatment: psychology: community medicine; and up to 5 people who, between them, have appropriate expertise in— (i) (ii) (iii) (iv) (v) up to 3 people employed in the Public Service (as de­ ﬁned in section 27 of the State Sector Act 1988) who between them have appropriate expertise in— (i) (ii) public health: the appropriateness and safety of pharmaceut­ icals and their availability to the public: border control; and (iii) 1 member of the police; and 1 employee of the Ministry of Justice who has appro­ priate expertise in matters relating to the justice system; and (b) (c) (ca) 15 s 5A Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 (4) (5) (d) 1 person representing the views of consumers of drug treatment services.
The Minister must appoint 1 member as chairperson of the Committee.

Subsections (2) and (3) of section 5 apply to the Expert Advisory Committee on Drugs as if it were a committee established under section 5.

Section 5AA was inserted, as from 15 November 2000, by section 5 Misuse of Drugs Amendment Act 2000 (2000 No 47).

Subsection (2)(b)(ii) was substituted, as from 22 June 2005, by section 7(1) Misuse of Drugs Amendment Act 2005 (2005 No 81).
Subsection (2)(b)(iii) was inserted, as from 22 June 2005, by section 7(1) Misuse of Drugs Amendment Act 2005 (2005 No 81).

Subsection (3)(ca) was inserted, as from 22 June 2005, by section 7(2) Misuse of Drugs Amendment Act 2005 (2005 No 81).

5A Approved laboratories (1) The Minister may from time to time, by notice in the Gazette, approve any laboratory for the purposes of this Act.
(2) Any approval by the Minister of a laboratory as an approved laboratory for the purposes of this Act may be given on such terms and conditions as the Minister thinks ﬁt and as are speciﬁed in the notice approving that laboratory.

(3) Any notice given by the Minister in the Gazette for the purposes of subsection (1) of this section shall be deemed to be a regulation for purposes of the Regulations (Disallowance) Act 1989 and the Acts Interpretation Act 1924.
This section was inserted, as from 1 July 1992, by section 3 Misuse of Drugs Amendment Act 1992 (1992 No 49).

Functions of Minister For the purposes of this Act, the functions of the Minister include the provision and publication of reports, information, and advice concerning the misuse of drugs and the treatment of persons suffering from the misuse of drugs.

Section 5B was inserted, as from 15 November 2000, by section 6 Misuse of Drugs Amendment Act 2000 (2000 No 47).
5B 16 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 6 6 (1) (2) Dealing with controlled drugs Except as provided in section 8 of this Act, or pursuant to a licence under this Act, or as otherwise permitted by regulations made under this Act, no person shall— (a) Import into or export from New Zealand any controlled drug, other than a controlled drug speciﬁed or described in Part 6 of Schedule 3 to this Act ; or Produce or manufacture any controlled drug; or Supply or administer, or offer to supply or administer, any Class A controlled drug or Class B controlled drug to any other person, or otherwise deal in any such con­ trolled drug; or Supply or administer, or offer to supply or administer, any Class C controlled drug to a person under 18 years of age; or Sell, or offer to sell, any Class C controlled drug to a person of or over 18 years of age; or Have any controlled drug in his possession for any of the purposes set out in paragraphs (c), (d), or (e) of this subsection.
(b) (c) (d) (e) (f) Every person who contravenes subsection (1) of this section commits an offence against this Act and is liable on conviction on indictment to— (a) Imprisonment for life where a Class A controlled drug was the controlled drug or one of the controlled drugs in relation to which the offence was committed: Imprisonment for a term not exceeding 14 years where paragraph (a) of this subsection does not apply but a Class B controlled drug was the controlled drug or one of the controlled drugs in relation to which the offence was committed: Imprisonment for a term not exceeding 8 years in any other case.
(b) (c) (2A) Every person who conspires with any other person to commit an offence against subsection (1) of this section commits an offence against this Act and is liable on conviction on indictment to imprisonment for a term— 17 s 6 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 (a) Not exceeding 14 years where a Class A controlled drug was the controlled drug or one of the controlled drugs in relation to which the offence was committed: (b) Not exceeding 10 years where paragraph (a) of this sub­ section does not apply but a Class B controlled drug was the controlled drug or one of the controlled drugs in re­ lation to which the offence was committed: Not exceeding 7 years in any other case.
(3) Notwithstanding anything in section 7 of the Summary Proceedings Act 1957, where any person is summarily convicted of an offence against this section relating to a Class C controlled drug, the District Court may sentence him to imprisonment for a term not exceeding one year or to a ﬁne not exceeding $1,000.
(c) (4) Notwithstanding anything in Part 1 or section 39 or section 81 of the Sentencing Act 2002, where any person is convicted of an offence relating to a Class A controlled drug— (a) Against paragraph (c) or paragraph (f) of subsection (1) of this section ; or (b) Against paragraph (a) or paragraph (b) of subsection (1) of this section committed in circumstances indicating to the Judge or Court an intention to offend against para­ graph (c) of that subsection,— the Judge or Court shall impose sentence of imprisonment (within the meaning of that Act) unless, having regard to the particular circumstances of the offence or of the offender, including the age of the offender if he is under 20 years of age, the Judge or Court is of the opinion that the offender should not be so sentenced.
(4A) Without limiting anything in subsections (3) and (4) of this section or in Part 1 or section 39 or section 81 of the Sentencing Act 2002, where any person is convicted of an offence relating to a Class A controlled drug or a Class B controlled drug against any of paragraphs (a), (b), (c), and (f) of subsection (1) of this section, the Judge or Court, if he or it decides to impose a sentence of imprisonment, shall consider whether or not he or it should also impose a ﬁne.
For the purposes of paragraph (e) of subsection (1) of this section, if it is proved that a person has supplied a controlled (5) 18 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 6 (6) (7) drug to another person he shall until the contrary is proved be deemed to have sold that controlled drug to that other person.
For the purposes of subsection (1)(f), a person is presumed until the contrary is proved to be in possession of a controlled drug for any of the purposes in subsection (1)(c), (d), or (e) if he or she is in possession of the controlled drug in an amount, level, or quantity at or over which the controlled drug is presumed to be for supply (see section 2(1A)).
Compare: 1965 No 45 s 5(1)(a), (b), (d), (e), (2), (3), (6) Subsection (1)(a) was substituted, as from 6 November 1986, by section 2 Misuse of Drugs Amendment Act 1986 (1986 No 102).

Subsection (2) was substituted, as from 16 October 1978, by section 3(1) Misuse of Drugs Amendment Act 1978 (1978 No 65).

Subsection (2A) was inserted, as from 16 October 1978, by section 4(1) Misuse of Drugs Amendment Act 1978 (1978 No 65).
Subsection (3) (as amended by sections 3(2) and 4(2) Misuse of Drugs Amendment Act 1978 (1978 No 65) ) was substituted, as from 13 January 1983, by section 3(1) Misuse of Drugs Amendment Act 1982 (1982 No 151).

Subsection (4) was substituted, as from 1 October 1985, by section 150(1) Criminal Justice Act 1985 (1985 No 120).
Subsection (4) was amended, as from 30 June 2002, by section 186 Sentencing Act 2002 (2002 No 9) by substituting the words “Part 1 or section 39 or section 81 of the Sentencing Act 2002”.

for the words “Part 1, or section 26, or section 72 of the Criminal Justice Act 1985”.

See clause 2 Sentencing Act Commencement Order 2002 (SR 2002/176).
Subsection (4) was amended as from 30 June 2002, by section 186 Sentencing Act 2002 (2002 No 9) by substituting the words “sentence of imprisonment” for the words “full­time custodial sentence”.

See clause 2 Sentencing Act Commencement Order 2002 (SR 2002/176).

Subsection (4A) was inserted, as from 16 October 1978, by section 5 Misuse of Drugs Amendment Act 1978 (1978 No 65) and substituted, as from 1 October 1985, by section 150(1) Criminal Justice Act 1985 (1985 No 120).
Subsection (4A) was amended, as from 30 June 2002, by section 186 Sentencing Act 2002 (2002 No 9) by substituting the words “Part 1 or section 39 or section 81 of the Sentencing Act 2002” for the words “Part 1, section 26, or section 72 of the Criminal Justice Act 1985”.

It was amended by substituting the words “sentence of imprisonment” for the words “full­time custodial sentence”.

See clause 2 Sentencing Act Commencement Order 2002 (SR 2002/176).
Subsection (6)(ca) was inserted, as from 13 January 1983, by section 3(3) Misuse of Drugs Amendment Act 1982 (1982 No 151).

Subsections (6)(cb) was inserted, as from 15 November 2000, by section 7(1) Misuse of Drugs Amendment Act 2000 (2000 No 47).

19 s 7 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 Subsection (6)(d) was amended, as from 2 September 1996, by section 3 Misuse of Drugs Amendment Act 1996 (1996 No 133) by substituting the words “Schedule 2” for the words “Schedule 1”.
Subsection (6)(e) was substituted, as from 13 January 1983, by section 3(4) Misuse of Drugs Amendment Act 1982 (1982 No 151).

Subsection (6) was substituted, as from 22 June 2005, by section 8 Misuse of Drugs Amendment Act 2005 (2005 No 81).

Subsection (7) was inserted, as from 15 November 2000, by section 7(2) Misuse of Drugs Amendment Act 2000 (2000 No 47).

Subsection (7) was repealed, as from 22 June 2005, by section 8 Misuse of Drugs Amendment Act 2005 (2005 No 81).
Possession and use of controlled drugs Except as provided in section 8 of this Act, or pursuant to a licence under this Act, or as otherwise permitted by regulations made under this Act, no person shall— (a) Procure or have in his possession, or consume, smoke, or otherwise use, any controlled drug; or Supply or administer, or offer to supply or adminis­ ter, any Class C controlled drug to any other person, or otherwise deal in any such controlled drug.
(b) Subject to subsection (3) of this section, but without prejudice to any liability under section 6 of this Act, every person who contravenes subsection (1) of this section commits an offence against this Act and is liable on conviction— (a) To imprisonment for a term not exceeding 6 months or to a ﬁne not exceeding $1,000 or to both where a Class A controlled drug was the controlled drug or one of the controlled drugs in relation to which the offence was committed: To imprisonment for a term not exceeding 3 months or to a ﬁne not exceeding $500 or to both in any other case: Provided that, where any person is convicted of an offence against subsection (1) of this section relating only to a Class C controlled drug and is liable to a penalty under paragraph (b) of this subsection, the Judge or District Court Judge shall not impose a custo­ dial sentence (being a sentence under which a person is liable to be detained in a prison within the meaning of the Corrections Act 2004) unless, by reason of the (b) 7 (1) (2) 20 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 8 offender’s previous convictions or of any exceptional circumstances relating to the offence or the offender, the Judge or District Court Judge is of the opinion that such a sentence should be imposed.
(3) In any proceedings for an offence against this section in respect of the possession of a controlled drug, in which it is proved that the defendant had a controlled drug in his possession, it shall be a defence for him to prove— (a) That, knowing or suspecting it to be a controlled drug, he took possession of it for the purpose of preventing another from committing or continuing to commit an offence in connection with that drug and that as soon as possible after taking possession of it he took all rea­ sonable steps to destroy the drug or to deliver it into the possession of a person lawfully entitled to have posses­ sion of it; or That, knowing or suspecting it to be a controlled drug, he took possession of it for the purpose of delivering it into the possession of a person lawfully entitled to have possession of it and that as soon as possible after taking possession of it he took all reasonable steps to deliver it into the possession of such a person.
(b) (4) Nothing in subsection (3) of this section shall prejudice any defence which it is open to a person charged with an offence against this section to raise apart from that subsection.

Compare: 1965 No 45 s 6 ; Misuse of Drugs Act 1971, s 5(4), (6) (UK) Subsection (2) was amended, as from 1 April 1980, pursuant to section 18(2) District Courts Amendment Act 1979 (1979 No 125) by substituting the words “District Court Judge” for the word “Magistrate”.
Subsection (2) was amended, as from 1 June 2005, by section 206 Corrections Act 2004 (2004 No 50) by substituting the words “prison within the meaning of the Corrections Act 2004” for the words “penal institution within the meaning of the Penal Institutions Act 1954”.

See clause 2 Corrections Act Commencement Order 2005 (SR 2005/52).
8 (1) Exemptions from sections 6 and 7 In subsection (2) of this section, references to a medical practitioner, dentist, veterinarian, midwife, designated prescriber, or pharmacist mean a medical practitioner, dentist, veterinarian, midwife, designated prescriber, or 21 s 8 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 pharmacist, acting as such in the course of his or her practice or employment, and references to the supply of controlled drugs include an offer to supply controlled drugs.
(2) Notwithstanding anything in section 6 or section 7 of this Act, but subject to sections 22 to 25 of this Act and any prohibitions, limitations, restrictions, or conditions, imposed thereby or thereunder or by or pursuant to any regulations under this Act,— (a) Any medical practitioner, dentist or veterinarian may prescribe, produce, manufacture, supply, or administer controlled drugs: (aa) Any midwife may prescribe, supply, or administer the controlled drug pethidine (as described in Schedule 2 to this Act ): any pharmacist or any person with the authority and under the immediate supervision of a pharmacist may produce, manufacture, or supply controlled drugs— (i) (b) listed in the pharmaceutical schedule within the meaning of the New Zealand Public Health and Disability Act 2000 for the purposes of a person eligible for a subsidy for the supply of controlled drugs; or for the purposes of the hospital in which he or she is employed; or pursuant to a prescription or order issued by a medical practitioner, dentist, designated pre­ scriber, or veterinarian: (ii) (iii) (ba) Any pharmacist or any person with the authority and under the immediate supervision of a pharmacist may produce, manufacture, or supply pethidine (as so de­ scribed) pursuant to a prescription or order issued by a midwife: Any person for whom a controlled drug is supplied by a medical practitioner or dentist, or prescribed by a med­ ical practitioner or dentist and lawfully supplied, may administer that drug to himself in accordance with the advice of the medical practitioner or dentist who sup­ plied or prescribed it: (c) 22 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 8 (d) Any person having the care of a patient for whom a controlled drug is supplied by a medical practitioner or dentist, or prescribed by a medical practitioner or dentist and lawfully supplied, may administer that drug to that patient in accordance with the advice of the medical practitioner or dentist who supplied or prescribed it: (e) (da) Any person having the
 care of a patient for whom pethi­ dine (as so described) is supplied by a midwife, or pre­ scribed by a midwife and lawfully supplied, may ad­ minister that drug to that patient in accordance with the advice of the midwife who supplied or prescribed it: Any person having the care of an animal for which a controlled drug is supplied by a veterinarian, or pre­ scribed by a veterinarian and lawfully supplied, may ad­ minister that drug to that animal in accordance with the advice of the veterinarian who supplied or prescribed it: Any district health board established by or under the New Zealand Public Health and Disability Act 2000 or other corporate body, and any individual person being the manager or person licensed to carry on a hospital or any other institution, having the care of patients for whom controlled drugs are lawfully prescribed or sup­ plied, may possess those drugs for the purposes of the treatment of those patients: (f) (g) Any person in the service of the Crown or any Med­ ical Ofﬁcer of Health or any pharmacist approved by a Medical Ofﬁcer of Health may procure and possess a controlled drug for the purposes of and in connection with his ofﬁcial duties: (i) (h) Any carrier may possess a controlled drug in the course of carriage to such extent as is necessary or incidental to his business: Any person who is permitted by or under this Act to import, export, supply, or administer a controlled drug may procure that drug from a person lawfully entitled to supply it and may possess that drug in the manner and for the purposes expressed or implied in that authority: Any person who is licensed or otherwise permitted under this Act to cultivate a prohibited plant may pos­ (j) 23 s 8 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 sess any controlled drug derived from that plant in the manner and for the purposes expressed or implied in that authority: (l) (k) Any person who is permitted by or under this Act to possess a controlled drug may procure that
 drug from a person lawfully entitled to supply it, and may supply or use that drug in the manner and for the purposes ex­ pressed or implied in that authority.
a person may, while entering or leaving New Zealand, possess a controlled drug required for treating the med­ ical condition of the person or any other person in his or her care or control, if the quantity of drug is no greater than that required for treating the medical condition for one month, and the drug was— (i) lawfully supplied to the person by a medical practitioner, designated prescriber (as deﬁned in section 2(1) of the Medicines Act 1981), or dentist in New Zealand; or prescribed by a medical practitioner, designated prescriber (as deﬁned in section 2(1) of the Medicines Act 1981), or dentist, and lawfully supplied to the person in New Zealand; or lawfully supplied to the person overseas and sup­ plied for the purpose of treating a medical condi­ tion.
(ii) (iii) (2A) Despite sections 6 and 7, but subject to sections 22 to 25 and restrictions, or conditions any prohibitions, imposed under those sections or any regulations made under this Act,— (a) limitations, A designated prescriber or any midwife who is author­ ised by regulations made under this Act to prescribe controlled drugs of any speciﬁed class or description, may prescribe, supply, or administer such drugs: (b) A person who is authorised to issue a standing order may include in a standing order authority to supply and administer controlled drugs of any speciﬁed class or de­ scription, and a person who is authorised under a stand­ ing order to supply and administer any controlled drugs 24 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 8 may supply and administer those drugs in accordance with that standing order.
(2B) (3) (b) In subsection (2A),— (a) References to a designated prescriber or a person au­ thorised under a standing order to supply and adminis­ ter any controlled drugs, mean a designated prescriber or person acting in the course of his or her practice or employment; and References to the supply of controlled drugs include an offer to supply controlled drugs.
Subject to section 22 of this Act and to any regulations under this Act and to any other enactment or rule of law prohibiting, restricting, or regulating the import, export, supply, or administration of drugs, any person may— (a) Import or export any controlled drug speciﬁed or de­ scribed in Part 6 of Schedule 3 to this Act: Supply or administer any controlled drug speciﬁed or described in the said Part 6.
(b) Compare: 1965 No 45 s 6(3) ; SR 1966/82, regs 2(2), 14, 15, 16(1), (a), (b), (e), 17(1), (2) as Section 8 was amended, from 22 December 2005, by section 105 Veterinarians Act 2005 (2005 No 126) by substituting the word “veterinarian” for the words “veterinary surgeon” wherever they appeared.

Subsection (1) was amended, as from 28 August 1990, by section 14(1) Nurses Amendment Act 1990 (1990 No 107) by inserting the words “registered midwife,” in two places, and the words “or her”.
Subsection (1) was amended, as from 22 October 2003, by section 3(1) Misuse of Drugs Amendment Act 2003 (2003 No 86) by inserting the words “designated prescriber,” after the words “registered midwife,” in both places where they occur.

Subsection (1) was amended, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48) by omitting the word “registered” in both places it occurred.

See sections 178 to 227 of that Act as to the transitional provisions.
Subsection (2)(aa) was inserted, as from 28 August 1990, by section 14(2) Nurses Amendment Act 1990 (1990 No 107).

Subsection (2)(aa) was amended, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48) by omitting the word “registered”.

See sections 178 to 227 of that Act as to the transitional provisions.

Subsection (2)(b) was substituted, as from 22 October 2003, by section 3(2) Misuse of Drugs Amendment Act 2003 (2003 No 86).
25 s 8 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 Subsection (2)(b) was amended, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48) by inserting the words “or any person with the authority and under the immediate supervision of a pharmacist” after the words “Any pharmacist”.

See sections 178 to 227 of that Act as to the transitional provisions.
Subsection (2)(ba) was inserted, as from 28 August 1990, by section 14(3) Nurses Amendment Act 1990 (1990 No 107).

Subsection (2)(ba) was amended, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48) by omitting the word “registered”.

See sections 178 to 227 of that Act as to the transitional provisions.
Subsection (2)(ba) was amended, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48) by inserting the words “or any person with the authority and under the immediate supervision of a pharmacist” after the words “Any pharmacist”.

See sections 178 to 227 of that Act as to the transitional provisions.

Subsection (2)(da) was inserted, as from 28 August 1990, by section 14(3) Nurses Amendment Act 1990 (1990 No 107).
Subsection (2)(da) was amended, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48) by omitting the word “registered” wherever it occurred.

See sections 178 to 227 of that Act as to the transitional provisions.

Subsection (2)(f) (as amended by section 98 Area Health Boards Act 1983 (1983 No 134) was substituted, as from 1 July 1983, by section 32 Health Reforms (Transitional Provisions) Act 1993 (1993 No 23).
Subsection (2)(f) was amended, as from 1 July 1998, by section 5(4) Health and Disability Services Amendment Act 1998 (1998 No 74) by substituting the words “hospital and health service” for the words “Crown health enterprise”.
Subsection (2)(f) was amended, as from 1 January 2001, by section 111(1) New Zealand Public Health and Disability Act 2000 (2000 No 91) by substituting the words “district health board established by or under the New Zealand Public Health and Disability Act 2000” for the words “hospital and health service”.

Subsection (2)(g) (as amended by section 98 Area Health Boards Act 1983 (1983 No 134) was substituted, as from 1 July 1983, by section 32 Health Reforms (Transitional Provisions) Act 1993 (1993 No 23).
Subsection (2)(l) was inserted, as from 15 November 2000, by section 8 Misuse of Drugs Amendment Act 2000 (2000 No 47).

Subsections (2A) and (2B) were inserted, as from 15 October 1999, by section 16 Medicines Amendment Act 1999 (1999 No 117).

Subsection (2A)(a) was amended, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48) by omitting the word “registered”.

See sections 178 to 227 of that Act as to the transitional provisions.
Subsection (3)(a) was amended, as from 2 September 1996, by section 4 Misuse of Drugs Amendment Act 1996 (1996 No 133) by omitting the words “Part 4, Part 5, or”.

26 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 10 9 (1) (2) Cultivation of prohibited plants Except pursuant to a licence under this Act, or as otherwise permitted by regulations made under this Act, no person shall cultivate any prohibited plant.
Subject to subsection (4) of this section, every person who contravenes subsection (1) of this section commits an offence against this Act and is liable on conviction on indictment to imprisonment for a term not exceeding 7 years.
(4) (3) Notwithstanding anything in section 7 of the Summary Proceedings Act 1957, where any person is summarily convicted of an offence against this section, the District Court may sentence him to imprisonment for a term not exceeding 2 years or to a ﬁne not exceeding $2,000 or to both.
It shall be a defence to a charge under subsection (1) of this section if the person charged proves that the prohibited plant to which the charge relates was of the species Papaver somniferum, and that it was not intended to be a source of any controlled drug or that it was not being developed as a strain from which a controlled drug could be produced.
Compare: 1965 No 45 s 5(1)(c), (2), (5) Subsection (3) was amended by substituting the words “District Court” for the words “Magistrate’s Court”, as from 1 April 1980, pursuant to section 18(2) District Courts Amendment Act 1979 (1979 No 125).
10 (1) Aiding offences against corresponding law of another country Every person commits an offence against this Act who, in New Zealand, aids, incites, counsels, or procures the doing or omission in any place outside New Zealand of any act, if that act or omission— (a) Is punishable under the provisions of any law corres­ ponding to section 6, 9, 12A, or 12AB and in force in that place; or (b) Would if done or omitted in New Zealand constitute an offence against section 6, 9, 12A, or 12AB.
(2) Every person who commits an offence against this section is liable on conviction on indictment to imprisonment for a term— 27 s 11 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 (a) Not exceeding 14 years where the relevant act or omis­ sion is punishable under the provisions of any law cor­ responding to section 6 of this Act or would if done or omitted in New Zealand constitute an offence against that section: (b) Not exceeding 7 years in any other case.
(3) Notwithstanding anything in section 7 of the Summary Proceedings Act 1957, where any person is summarily convicted of an offence against this section, the District Court may sentence him to imprisonment for a term not exceeding 3 years or to a ﬁne not exceeding $2,000 or to both.
It is a defence to a charge under paragraph (b) of subsection (1) of this section if the doing or omission of the act to which the charge relates was not an offence under the law of the place where it was, or was to be, done or omitted.

(4) (5) Nothing in subsection (1) or subsection (4) of this section shall derogate from any provision in the Crimes Act 1961.
Compare: 1965 No 45 s 5A ; 1970 No 27 s 3 Subsection (1)(a) and (b) was amended, as from 22 June 2005, by section 9 Misuse of Drugs Amendment Act 2005 (2005 No 81) by substituting the words “, 9, 12A, or 12AB” for the words “or section 9 of this Act”.

Subsection (3) has been amended by substituting the words “District Court” for the words “Magistrate’s Court”, as from 1 April 1980, pursuant to section 18(2) District Courts Amendment Act 1979 (1979 No 125).
Subsection (4) was amended, as from 12 May 1998, by section 4 Misuse of Drugs Amendment Act 1998 (1998 No 14) by omitting the words “the person charged proves that”.

Subsection (6) was repealed, as from 1 September 1999, by section 111 Extradition Act 1999 (1999 No 55).
Theft, etc, of controlled drugs Every person commits an offence against this Act and is liable on conviction on indictment to imprisonment for a term not exceeding 7 years who— (a) (b) With intent to defraud by any false pretence, either di­ rectly or through the medium of any contract obtained by the false pretence, obtains possession of or title to a Steals a controlled drug; or (6) 11 (1) 28 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 12 (2) (3) 12 (1) (2) (c) controlled drug, or procures a controlled drug to be de­ livered to any person other than himself; or receives a controlled drug obtained by any crime, or by any act, wherever committed, that, if committed in New Zealand, would constitute a crime, knowing that the controlled drug had been dishonestly obtained or being reckless as to whether or not the controlled drug had been stolen or so obtained.
Section 246(2) to (5) of the Crimes Act 1961 shall apply in respect of any proceedings for an offence against paragraph (c) of subsection (1) of this section.

The deﬁnition of crime in section 2, and sections 219, 220, 222, 240, and 246(2) to (5) of the Crimes Act 1961, shall apply, with such modiﬁcations as may be necessary, for the purpose of construing subsection (1) of this section.
Compare: 1965 No 45 s 6A ; 1970 No 27 s 4(1) Subsection (1)(c) was substituted, as from 1 October 2003, by section 34 Crimes Amendment Act 2003 (2003 No 39).

Subsection (2) was amended, as from 1 October 2003, by section 34 Crimes Amendment Act 2003 (2003 No 39) by substituting the words “Section 246(2) to (5)” for the words “Subsections (2) and (3) of section 258”.
Subsection (3) was amended, as from 1 September 1995, by section 4(3) Crimes Amendment Act 1995 (1995 No 49) by omitting the expression “259,”.

Subsection (3) was amended, as from 1 October 2003, by section 34 Crimes Amendment Act 2003 (2003 No 39) by substituting the words “sections 219, 220, 222, 240, and 246(2) to (5)” for the words “sections 220, 222, 225, 226, 245, 260, and 261”.
Use of premises or vehicle Every person commits an offence against this Act who knowingly permits any premises or any vessel, aircraft, hovercraft, motor vehicle, or other mode of conveyance to be used for the purpose of the commission of an offence against this Act.
Every person who commits an offence against this section is liable on conviction on indictment to imprisonment for a term— (a) Not exceeding 10 years where a Class A controlled drug was the controlled drug or one of the controlled drugs in relation to which the offence was committed: 29 s 12A Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 (c) (b) Not exceeding 7 years where paragraph (a) of this sub­ section does not apply but a Class B controlled drug was the controlled drug or one of the controlled drugs in re­ lation to which the offence was committed: Not exceeding 3 years in any other case.
(3) Notwithstanding anything in section 7 of the Summary Proceedings Act 1957, where any person is summarily convicted of an offence against this section the District Court may sentence him— (a) To imprisonment for a term not exceeding 2 years or to a ﬁne not exceeding $1,000 or to both where he could have been sentenced under paragraph (a) of subsection (2) of this section if he had been convicted on indict­ ment: To imprisonment for a term not exceeding one year or to a ﬁne not exceeding $1,000 or to both where he could have been sentenced under paragraph (b) of subsection (2) of this section if he had been convicted on indict­ ment: To imprisonment for a term not exceeding 6 months or to a ﬁne not exceeding $500 or to both in any other case.
(b) (c) Compare: 1965 No 45 s 7(1)(a) Subsection (1) was amended, as from 16 October 1978, by section 6 Misuse of Drugs Amendment Act 1978 (1978 No 65) by substituting the words “any vessel, aircraft, hovercraft, motor vehicle, or other mode of conveyance” for the word “vehicle”.

Subsection (3) was amended, as from 1 April 1980, by substituting the words “District Court” for the words “Magistrate’s Court” pursuant to section 18(2) District Courts Amendment Act 1979 (1979 No 125).
12A Equipment, material, and substances used in production or cultivation of controlled drugs Every person commits an offence against supplies, produces, or manufactures— (a) Any equipment or material that is capable of being used in, or for, the commission of an offence against section 6(1)(b) or section 9 ; or this Act who (b) Any precursor substance— (1) 30 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 12AB (2) (3) (4) knowing that the equipment, material, or substance is to be used in, or for, the commission of an offence against those provisions.
Every person commits an offence against this Act who has in his or her possession— (a) Any equipment or material that is capable of being used in, or for, the commission of an offence against section 6(1)(b) or section 9 ; or (b) Any precursor substance— with the intention that the equipment, material, or substance is to be used in, or for, the commission of an offence against that provision.
Every person who commits an offence against this section is liable on conviction on indictment,— (a) In the case of an offence against subsection (1), to im­ prisonment for a term not exceeding 7 years: In the case of an offence against subsection (2), to im­ prisonment for a term not exceeding 5 years.
(b) If a person is summarily convicted of an offence against this section,— (a) The Court may sentence the person to imprisonment for a term not exceeding 1 year or to a ﬁne not exceeding $1,000, or to both; and The sentencing limits contained in section 7 of the Summary Proceedings Act 1957 do not apply.

Sections 12A to 12C were inserted, as from 12 May 1998, by section 5 Misuse of Drugs Amendment Act 1998 (1998 No 14).
(b) 12AB Offence to knowingly import or export precursor (1) substances for unlawful use Every person commits an offence who— (a) imports into New Zealand any precursor substance knowing that it will be used to commit an offence under section 6(1)(b) (which is the offence of produc­ ing or manufacturing any controlled drug); or exports from New Zealand any precursor substance knowing that it will be used to commit an offence under a provision of the law of the country to which the (b) 31 s 12AC Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 precursor substance is being exported that corresponds to an offence under section 6(1)(b).
(3) (2) A person who commits an offence under subsection (1) is liable on conviction on indictment to imprisonment for a term not exceeding 7 years.

If a person is summarily convicted of an offence under subsection (1),— (a) a court may sentence the person to imprisonment for a term not exceeding 1 year or a ﬁne not exceeding $1,000, or both; and the sentencing limits contained in section 7 of the Summary Proceedings Act 1957 do not apply.
Sections 12AB and 12AC were inserted, as from 22 June 2005, by section 10 Misuse of Drugs Amendment Act 2005 (2005 No 81).

(b) 12AC Offence to import or export precursor substance without (1) reasonable excuse Every person commits an offence who, without reasonable imports into, or exports from, New Zealand any excuse, precursor substance.
(2) Without limiting the circumstances under subsection (1) in which a person may have a reasonable excuse, a person has a reasonable excuse if— (a) he or she imports a precursor substance into New Zealand in order that— (i) a medical practitioner, dentist, or veterinarian may, in the circumstances referred to in section 8(2)(a), produce or manufacture a controlled drug from the precursor substance; or a pharmacist or any person with the authority and under the immediate supervision of a pharmacist may, in any of the circumstances referred to in section 8(2)(b), produce or manufacture a con­ trolled drug from the precursor substance; or the precursor substance be used for a lawful pur­ pose (including, without limitation, an agricul­ tural, commercial, or industrial purpose); or (ii) (iii) 32 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 12B (b) (c) the precursor substance that he or she is importing into, or exporting from, New Zealand has been lawfully sup­ plied to that person for his or her own medical use; or he or she exports a precursor substance from New Zealand in order that the precursor substance be used for a purpose that is authorised or lawful under the law of the country to which it is being exported.
in section 67(8) of the Summary The requirements Proceedings Act 1957 relating to proof of any exception, excuse, or qualiﬁcation do not apply to an offence under subsection (1).

By way of explanation, the effect of subsection (3) is that, in order for a prosecution to be successful, the prosecution must negate beyond a reasonable doubt any reasonable excuse in dispute (being any matter raised as a reasonable excuse by the defendant).
(3) (4) (5) A person who commits an offence under subsection (1) is liable on summary conviction to imprisonment for a term not exceeding 1 year or a ﬁne not exceeding $1,000, or both.

Sections 12AB and 12AC were inserted, as from 22 June 2005, by section 10 Misuse of Drugs Amendment Act 2005 (2005 No 81).
12B Laundering proceeds of drug offences (1) In this section,— Conceal, in relation to property,— (a) Means to conceal or disguise the property; and (b) Includes (without limitation)— (i) (ii) To convert the property from one form to another: source, To conceal or disguise the nature, the location, disposition, or ownership of property or of any interest in the property: Deal with, in relation to property,— (a) Means to deal with the property in any manner and by (b) any means; and Includes (without limitation)— (i) To dispose of the property, whether by way of sale, purchase, gift, or otherwise: To transfer possession of the property: (ii) (iii) To bring the property into New Zealand: 33 s 12B Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 (iv) To remove property from New Zealand: Interest, in relation to property, means— (a) (b) A right, power, or privilege in connection with the A legal or equitable estate or interest in the property: property: Proceeds, in relation to a speciﬁed drug offence, means any property that is derived or realised, directly or indirectly, by any person from the commission of the offence Property — (a) Means real or personal property of any description, whether situated in New Zealand or elsewhere and whether tangible or intangible; and Includes an interest property: in any such real or personal (b) Serious offence has the same meaning as it has in section 243 of the Crimes Act 1961 Serious offence: this deﬁnition was amended, as from 1 October 2003, by section 34 Crimes Amendment Act 2003 (2003 No 39) by substituting the expression “section 243” for the expression “section 257A”.
Speciﬁed drug offence — (a) Means an offence against section 6 or section 9 or (b) section 12A or section 12AB; and Includes any act, wherever committed, which if committed in New Zealand would constitute an offence against any of those sections.

Speciﬁed drug offence: paragraph (a) of this deﬁnition was amended, as from 22 June 2005, by section 11 Misuse of Drugs Amendment Act 2005 (2005 No 81) by inserting the words “or section 12AB” after the expression “section 12A”.
Subject to subsections (6) to (8), every person commits an offence and is liable on conviction on indictment to in imprisonment for a term not exceeding 7 years who, respect of any property that is the proceeds of a speciﬁed drug offence, engages in a money laundering transaction, knowing or believing that all or part of the property is the proceeds of a speciﬁed drug offence, or being reckless as to whether or not the property is the proceeds of a speciﬁed drug offence.
Subject to subsections (6) to (8), every person commits to an offence and is liable on conviction on indictment imprisonment for a term not exceeding 5 years who obtains or (2) (3) 34 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 12B has in his or her possession any property (which property is the proceeds of a speciﬁed drug offence committed by another person)— (a) with intent to engage in a money laundering transaction concerning that property; and knowing or believing that all or part of the property is the proceeds of a speciﬁed drug offence, or being reckless as to whether or not the property is the proceeds of a speciﬁed drug offence.
(b) For the purposes of this section, a person engages in a money laundering transaction if that person— Deals with any property; or (a) (b) Assists any other person, whether directly or indirectly, to deal with any property— for the purpose of— Concealing that property; or (c) (d) Enabling another person to conceal that property.
In any prosecution for an offence against subsection (2) or subsection (3),— (a) It is not necessary for the prosecution to prove that the accused knew or believed that the property was the pro­ ceeds of a particular speciﬁed drug offence or a particu­ lar class of speciﬁed drug offence: It is no defence that the accused believed any property to be the proceeds of a particular speciﬁed drug offence, when in fact the property was the proceeds of another speciﬁed drug offence.
(b) It is a defence to a charge under this section if the act to which the charge relates was done by that person, in good faith, for the purpose of or in connection with— (a) The enforcement or intended enforcement of this sec­ tion or any other provision of this Act or any other en­ actment relating to a speciﬁed drug offence or any other serious offence; or The enforcement or Proceeds of Crime Act 1991 ; or The enforcement or Financial Transactions Reporting Act 1996.
Subject to subsection (8), this section does not apply if— intended enforcement of intended enforcement of the the (b) (c) 35 (4) (5) (6) (7) s 12C Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 (c) (a) (b) Any property is alleged to be the proceeds of a serious offence; and The act that is alleged to constitute that serious offence was committed outside New Zealand; and The act was not, at the time of its commission, an of­ fence under the law of the place where the act was done.
If a person is charged with an offence against this section and the act that is alleged to constitute the serious offence resulting in proceeds was committed outside New Zealand, it is to be presumed, unless the person charged puts the matter at issue, that the act was an offence under the law of the place where the act was done.

(8) (9) Nothing in this section limits or restricts the operation of any other provision of this Act or any other enactment.
Sections 12A to 12C were inserted, as from 12 May 1998, by section 5 Misuse of Drugs Amendment Act 1998 (1998 No 14).

Subsections (2) and (3) were substituted, as from 1 October 2003, by section 34 Crimes Amendment Act 2003 (2003 No 39).
12C Commission of offences outside New Zealand (1) Subject to subsection (2), every person commits an offence against this Act who, outside New Zealand, does or omits to do any act that would, if done or omitted in New Zealand, constitute an offence against— (a) (b) (c) (ca) (d) Section 6 ; or Section 9 ; or Section 12A ; or section 12AB; or Section 12B.
(2) No proceedings for an offence against subsection (1) may be The person to be charged is a New Zealand citizen; or The person to be charged is present in New Zealand.

brought unless— (a) (b) Every person who commits an offence against this section is liable on conviction on indictment to the same penalty to which the person would have been liable had that person committed the offence in New Zealand.
(3) 36 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 13 (4) Subsection (1) does not apply if the doing or omission of the act to which the charge relates was not an offence under the law of the place where the act was done or omitted.
(5) Despite subsection (4), if a person is charged with an offence against this section, it is to be presumed, unless the person charged puts the matter at issue, that the doing or omission of the act to which the charge relates was an offence under the law of the place where the act was done or omitted.

Section 28A applies to proceedings for offences against this section.

Sections 12A to 12C were inserted, as from 12 May 1998, by section 5 Misuse of Drugs Amendment Act 1998 (1998 No 14).
(6) Subsection (1)(ca) was inserted, as from 22 June 2005, by section 12 Misuse of Drugs Amendment Act 2005 (2005 No 81).
13 Miscellaneous offences (1) Every person commits an offence against this Act who— (a) Has in that person’s possession any pipe or other utensil (not being a needle or syringe) for the purpose of the commission of an offence against this Act; or has in that person’s possession for the purpose of com­ mitting an offence under this Act any needle or sy­ ringe— (i) (aa) that he or she obtained from a person (a supplier) who he or she could not have reasonably believed at the time of the acquisition was a pharmacist, pharmacy employee, approved medical practi­ tioner, or an authorised representative; or that another person (an acquirer) obtained on his or her behalf from a supplier who the ac­ quirer could not have reasonably believed at the time the needle or syringe was obtained was a pharmacist, pharmacy employee, approved med­ ical practitioner, or an authorised representative; or other than a needle or syringe that he or she ob­ tained in accordance with any regulations made under section 37 that regulate the sale, exchange, or supply of needles or syringes; or (ii) (iii) 37 s 13 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 (iv) other than a needle or syringe that the acquirer obtained on his or her behalf in accordance with any regulations made under section 37 that regu­ late the sale, exchange, or supply of needles or syringes; or Except as may be provided by regulations made under this Act, has in his possession the seed or fruit (not in either case being a controlled drug) of any prohibited plant which he is not authorised under this Act to culti­ vate.
(b) (2) Subsection (4) of section 9 of this Act shall apply in relation to a charge under paragraph (b) of subsection (1) of this section as if, in the said subsection (4), a reference to the seed or fruit of a prohibited plant were substituted for the reference to the prohibited plant.
(4) (3) (2A) No pharmacist, pharmacy employee, approved medical practitioner, or authorised representative commits an offence by selling or supplying any needle or syringe in accordance with any regulations made under section 37 that regulate the sale, exchange, or supply of needles or syringes.

Every person who commits an offence against this section is liable to imprisonment for a term not exceeding one year or to a ﬁne not exceeding $500 or to both.
For the purposes of this section, unless the context otherwise requires,— approved medical practitioner means a medical practitioner who has been approved by the Director­General of Health under any regulations made under section 37 for the purposes of those regulations authorised representative means, in relation to an agency, an association, or a body approved by the Director­General of Health, a person for the time being approved by the Director­General as a representative of that agency, association, or body needle means a needle forming part of, or attached to, or designed for attachment to and use with, a syringe 38 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 14 pharmacy employee means a person employed in a pharmacy within the meaning of the Medicines Act 1981.
Compare: 1965 No 45 s 7 Subsection (1)(a) was substituted, and (1)(aa) inserted, as from 13 January 1988, by section 3 Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193).

Subsection (1)(aa) was substituted, as from 22 June 2005, by section 13(1) Misuse of Drugs Amendment Act 2005 (2005 No 81).

Subsection (2A) was inserted, as from 22 June 2005, by section 13(2) Misuse of Drugs Amendment Act 2005 (2005 No 81).
Subsection (4) was inserted, as from 22 June 2005, by section 13(3) Misuse of Drugs Amendment Act 2005 (2005 No 81).

14 (1) Licences Licences granted under this Act shall be in such form and be subject to such conditions as may be prescribed, or permitted to be designed or imposed, and shall be issued by such persons as may be prescribed, by regulations made under this Act.

(3) (4) (2) No licence to import into or export from New Zealand opium prepared for smoking shall be granted under this Act.
Except in the case of a licence issued for the purpose of research or study, no licence granted under this Act shall authorise the consumption, injection, or smoking of any controlled drug.
Except with the approval of the Minister, no licence shall be granted under this Act to any person who has been convicted of an offence against this Act or any Act repealed by this Act or by the Narcotics Act 1965 or whose licence under any such Act has been revoked by reason of his failure to comply with the conditions thereof or by reason of the breach of the provisions of any such Act or of any regulation made thereunder.
If at any time the laws of a country or territory prohibit or restrict the importation of a controlled drug into that country or territory, any licence to export that controlled drug from New Zealand may contain conditions calculated to prevent any contravention of those laws in relation to the controlled drug which is the subject of the licence.
(5) (6) Without prejudice to his liability under any other provision of this Act, every person commits an offence against this Act who 39 s 15 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 15 contravenes or fails to comply with any condition of a licence granted to him under this Act.
Compare: 1965 No 45 s 8 ; SR 1966/82, reg 4(8) ; SR 1973/100, reg 3 False statements Every person commits an offence against this Act and is liable to imprisonment for a term not exceeding one year or to a ﬁne not exceeding $1,000 or to both who, for the purpose of obtaining, whether for himself or any other person, the grant or renewal of any licence under this Act or for any other purpose in relation to this Act,— (a) Makes any declaration or statement which to his know­ ledge is false in any particular; or (b) Utters, produces, or makes use of any declaration or statement which to his knowledge is false in any par­ ticular; or Knowingly utters, produces, or makes use of any docu­ ment that is not genuine.
(c) Compare: 1965 No 45 s 9 16 Obstruction of ofﬁcers Every person commits an offence against this Act who wilfully obstructs, hinders, resists, or deceives any other person in the execution of any powers conferred on that other person by or pursuant to this Act.
Compare: 1965 No 45 s 10 Liability of principal for acts of agent, etc 17 (1) Where an offence is committed against this Act or against any regulation made under this Act by any person acting as the agent or servant of another person, or being otherwise subject to the supervision or instructions of another person for the purposes of any employment in the course of which the offence was committed, that other person shall, without prejudice to the liability of the ﬁrst mentioned person, be liable under this Act in the same manner and to the same extent as if he had personally committed the offence if it is proved that the act which constituted the offence was committed with his consent 40 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 18 or connivance or that it was attributable to any neglect on his part.
(2) Where any body corporate is convicted of an offence against this Act or against any regulation made under this Act, every director and every person concerned in the management of the company shall be guilty of a like offence if it is proved that the act which constituted the offence was committed with his consent or connivance or that it was attributable to any neglect on his part.
Compare: 1965 No 45 s 11 Search and seizure 18 (1) Where a search warrant is issued under section 198 of the Summary Proceedings Act 1957 in respect of an offence which has been or is suspected to have been committed against this Act or which is believed to be intended to be so committed, any constable executing the warrant or any of his assistants may search any person found in or on the building, aircraft, ship, hovercraft, carriage, vehicle, premises, or place which may be entered and searched under the authority of the warrant.
(2) Where any member of the Police has reasonable ground for believing that there is in or on any building, aircraft, ship, hovercraft, carriage, vehicle, premises, or place any controlled drug speciﬁed or described in Schedule 1 or in Part 1 of Schedule 2 or in Part 1 of Schedule 3 to this Act or any precursor substance speciﬁed or described in Part 3 of Schedule 4 and that an offence against this Act has been or is suspected of having been committed in respect of that drug or precursor substance, he, and any assistants who accompany him, may enter and search the building, aircraft, ship, hovercraft, carriage, vehicle, premises, or place and any person found therein or thereon as if authorised to do so by a search warrant issued under section 198 of the Summary Proceedings Act 1957 and by subsection (1) of this section.
(3) Where any member of the Police has reasonable ground for believing that any person is in possession of any controlled drug speciﬁed or described in Schedule 1 or in Part 1 of Schedule 2 or in Part 1 of Schedule 3 to this Act or any precursor substance speciﬁed or described in Part 3 of 41 s 18 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 Schedule 4 and that an offence against this Act has been or is suspected of having been committed in respect of that drug or precursor substance, he may search and detain that person for the purpose of search and may take possession of any controlled drug or precursor substance found.
Nothing in this subsection shall limit the provisions of subsections (1) and (2) of this section or authorise any member of the Police to enter and search any building, aircraft, ship, hovercraft, carriage, vehicle, premises, or place otherwise than in accordance with the provisions of those subsections.
If it is necessary for a member of the Police to stop a vehicle for the purpose of exercising the power conferred by subsection (3) to search a person who is in the vehicle, sections 314B to 314D of the Crimes Act 1961 apply with any necessary modiﬁcations as if references in those sections to a statutory search power are references to subsection (3).
Every member of the Police exercising the power of entry and search conferred by subsection (2) of this section or the power conferred by subsection (3) of this section shall identify himself to every person searched, and also to any person in or on the building, aircraft, ship, hovercraft, carriage, vehicle, premises, or place who questions his right to enter and search the same, and shall also tell those persons that the search is being made pursuant to the authority of that subsection.
He shall also, if not in uniform and if so required, produce evidence that he is a member of the Police.
(3A) (4) (5) Any ofﬁcer of Customs, or any ofﬁcer of the Ministry of Health, or any Medical Ofﬁcer of Health, or any member of the Police, with such assistants as he thinks necessary, may seize and destroy any prohibited plant except where it is being cultivated either in accordance with the conditions of a licence granted under this Act or in accordance with regulations made under this Act, and may also seize and destroy the seed of any prohibited plant except where that seed is in the possession of any person who is either authorised under this Act to cultivate the plant or who is permitted by regulations made under this Act to have the seed in his possession.
(6) Where any member of the Police exercises the power of entry and search conferred by subsection (2) of this section or the 42 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 18A power conferred by subsection (3) of this section, he shall, within 3 days after the day on which he exercises the power, furnish to the Commissioner of Police a written report on the exercise of the power and the circumstances in which it came to be exercised.
Compare: 1965 No 45 s 12 Subsection (2) was amended, as from 22 June 2005, by section 14(1)(a) Misuse of Drugs Amendment Act 2005 (2005 No 81) by inserting the words “or any precursor substance speciﬁed or described in Part 3 of Schedule 4” after the words “Schedule 3 to this Act”.

Subsection (2) was amended, as from 22 June 2005, by section 14(1)(b) Misuse of Drugs Amendment Act 2005 (2005 No 81) by inserting the words “or precursor substance” after the words “in respect of that drug”.
Subsection (3) was amended, as from 22 June 2005, by section 14(2)(a) Misuse of Drugs Amendment Act 2005 (2005 No 81) by inserting the words “or any precursor substance speciﬁed or described in Part 3 of Schedule 4” after the words “Schedule 3 to this Act”.

Subsection (3) was amended, as from 22 June 2005, by section 14(2)(b) Misuse of Drugs Amendment Act 2005 (2005 No 81) by inserting the words “or precursor substance” after the words “in respect of that drug”.
Subsection (3) was amended, as from 22 June 2005, by section 14(2)(c) Misuse of Drugs Amendment Act 2005 (2005 No 81) by inserting the words “or precursor substance” after the words “any controlled drug” in the second place where they appear.

Subsection (3A) was inserted, as from 1 January 1998, by section 25 Crimes Amendment Act (No 2) 1997 (1997 No 93).
Subsection (5) (as amended by section 98 Area Health Boards Act 1983 (1983 No 134)) was amended, as from 1 July 1993, by section 32 Health Reforms (Transitional Provisions) Act 1993 (1993 No 23) by substituting the words “or any Medical Ofﬁcer of Health” for the words “or any Medical Ofﬁcer of Health or any pharmacist employed by an area health board”.
Subsection (5) was amended, as from 1 July 1993, by substituting the words “Ministry of Health” for the words “Department of Health” pursuant to section 38(3) Health Amendment Act 1993 (1993 No 24).
18A Internal search of person under arrest (1) Notwithstanding anything in section 57A of the Police Act 1958 or any other enactment or rule of law to the contrary, no member of the Police shall conduct an internal search of any part of the body of any person nor, except in accordance with subsection (2) of this section, shall he cause any other person to conduct such a search: Provided that, with the consent of the person concerned, a member of the Police may search that person’s mouth.
43 s 18A Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 (2) Where any person (in this section referred to as the suspect) is arrested for any offence against section 6 or section 7 or section 11 of this Act, a commissioned ofﬁcer or non­commissioned ofﬁcer of the Police who has reasonable ground for believing that the suspect has secreted within his body any property that may be evidence of the offence with which the suspect is charged, or any property the possession of which by the suspect constitutes any other offence against any of the said provisions, may require the suspect to permit a medical practitioner, nominated for the purpose by the ofﬁcer, to conduct an internal examination of any part of the suspect’s body by means of an X­ray machine or other similar device, or by means of a manual or visual examination (whether or not facilitated by any instrument or device) through any body oriﬁce.
(3) Notwithstanding anything in subsection (2) of this section or the terms of any requirement made under that section, no medical practitioner shall conduct any such internal examination if he considers that to do so may be prejudicial to the suspect’s health, or if he is satisﬁed that the suspect is not prepared to permit an internal examination to be conducted.
(4) Notwithstanding anything in the Summary Proceedings Act 1957 or this Act, where the suspect fails to permit an internal examination to be conducted under this section and subsequently applies for bail, the Court may (without limiting its discretion to refuse bail) decline to consider the application until the expiry of 2 days after the day on which the requirement to do so was made or until the suspect sooner permits such an examination to be conducted, if the Court is satisﬁed that the requirement was properly made on reasonable grounds; and, in any such case, the Court may order that the suspect shall continue to be detained in police custody until the expiry of that period or until the suspect sooner complies, as the case may be.
(5) Nothing in this section shall limit or affect the provisions of sections 13A to 13M of the Misuse of Drugs Amendment Act 1978.

This section was inserted, as from 12 December 1979, by section 2 Misuse of Drugs Amendment Act (No 2) 1979 (1979 No 132).

44 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 19 Subsection (2) was amended, as from 13 January 1983, by section 4 Misuse of Drugs Amendment Act 1982 (1982 No 151) by substituting the word “section” for the word “subsection”.
Subsection (5) was inserted, as from 1 October 1985, by section 3 Misuse of Drugs Amendment Act 1985 (1985 No 130).
19 Power to demand production of records and to inspect stocks of controlled drugs (2) (1) Any member of the Police or any other person authorised by the Minister shall for the purposes of the enforcement of the provisions of this Act have power to enter the premises of any person who carries on the business of a producer, manufacturer, seller, or distributor of any controlled drug, or who otherwise undertakes the supply or administration of any controlled drug, and to demand the production of and to inspect any books or documents relating to dealings in any controlled drug, and to inspect, weigh, measure, and record the stocks of controlled drugs.
If in the opinion of any Medical Ofﬁcer of Health there is reasonable ground for suspecting that any person is in possession of any controlled drug for the purpose of sale, or for the purpose of manufacturing any preparation for sale, or for use in or in connection with his profession, trade, or calling, or any occupation whether paid or unpaid, in breach of this Act or of any regulations made under this Act, the Medical Ofﬁcer of Health may require that person to produce for his inspection or to produce to any person specially authorised by the Medical Ofﬁcer of Health in that behalf, any books or documents dealing with the reception, possession, purchase, sale, or delivery of the controlled drug.
(3) Any person acting under, or pursuant to an authority under, subsection (1) or subsection (2) of this section may make copies of or extracts from any such books or documents, and the copies or extracts, certiﬁed as such by that person, shall be deemed to be true and correct copies or extracts, unless the contrary is proved.

Every person commits an offence against this Act who refuses or neglects to comply with any demand or requisition made pursuant to this section.
(4) 45 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 Compare: 1965 No 45 s 13 Subsection (5) was repealed, as from 1 April 1987, by section 25(1) Ofﬁcial Information Amendment Act 1987 (1987 No 8).
Statements regarding drug dependent persons If a Medical Ofﬁcer of Health has reason to believe that any person is or is likely to become dependent on any controlled drug, he may, for the purpose of preventing or restricting the supply of controlled drugs to that person, or of assisting in the cure or mitigation or avoidance of the dependence of that person, publish statements relating to that person to all or any of the members of all or any of the classes of persons set out in subsection (3) of this section.
Every statement made under subsection (1) of this section shall be privileged unless the publication is proved to be made with malice.
The classes of persons referred to in subsection (1) of this section are as follows: (a) employees of any district health board established by or under the New Zealand Public Health and Disability Act 2000: (aa) a hospital care operator within the meaning of section 58(4) of the Health and Disability Services (Safety) Act 2001: (b) (c) managers of prisons within the meaning of the Corrections Act 2004: (d) Managers and superintendents of institutions within the meaning of the Alcoholism and Drug Addiction Act 1966: Dentists: (e) Medical practitioners: (f) (fa) midwives: (fb) Designated prescribers: (g) Members of the Police: (h) Persons who deal in controlled drugs in the course of business.
s 20 (5) 20 (1) (2) (3) 46 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 20 (5) (4) Nothing in subsection (1) or subsection (2) of this section shall limit or affect any right or duty which a Medical Ofﬁcer of Health may otherwise possess to publish a statement to any person.
Every person commits an offence against this Act who, except in the course of duty as a member of a class set out in subsection (3) of this section or as an ofﬁcer or servant of the Crown, publishes any information obtained, whether by him or any other person, from a statement made pursuant to subsection (1) of this section, or any comment on any such statement.
Compare: 1965 No 45 s 20 Subsection (3)(a) (as substituted by section 98 Area Health Boards Act 1983 (1983 No 134)) was substituted, as from 1 July 1993, by section 32 Health Reforms (Transitional Provisions) Act 1993 (1993 No 23).

Subsection (3)(a) was amended, as from 1 July 1998, by section 5(4) Health and Disability Services Amendment Act 1998 (1998 No 74) by substituting the words “the Health Funding Authority” for the words “regional health authorities”.
Subsection (3)(a) was substituted, as from 1 January 2001, by section 111(1) New Zealand Public Health and Disability Act 2000 (2000 No 91).

Subsection (3)(aa) was repealed, as from 1 July 1993, by section 32 Health Reforms (Transitional Provisions) Act 1993 (1993 No 23).

Subsection (3)(b) was substituted, as from 1 July 1993, by section 32 Health Reforms (Transitional Provisions) Act 1993 (1993 No 23).
Subsection (3)(b) was substituted, as from 1 October 2002 by section 58(1) Health and Disability Services (Safety) Act 2001 (2001 No 93).

See section 11 of that Act for transitional provisions.

Subsection (3)(c) was substituted, as from 1 June 2005, by section 206 Corrections Act 2004 (2004 No 50).

See clause 2 Corrections Act Commencement Order 2005 (SR 2005/52).

Subsection (3)(fa) was inserted, as from 28 August 1990, by section 15 Nurses Amendment Act 1990 (1990 No 107).
Subsection (3)(fa) was amended, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48) by omitting the word “registered”.

See sections 178 to 227 of that Act as to the transitional provisions.

Subsection (3)(fb) was inserted, as from 15 October 1999, by section 16 Medicines Amendment Act 1999 (1999 No 117).
47 s 21 21 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 Power of Court to restrict publication of name of controlled drug (1) Where, in the course of proceedings in any Court or before a Coroner, reference is made to any controlled drug, the Court or Coroner may in its or his discretion order that the name of that drug shall not be published in relation to those proceedings at any time before the expiration of a period of 5 years from the date of the ﬁnal disposal of those proceedings: Provided that no order made under this subsection shall apply to the publication of that name to scientists or to members of the legal, medical, dental, veterinary, nursing, or pharmaceutical professions or to persons studying to become scientists or members of those professions or in any publication of a scientiﬁc or technical character solely or mainly intended for circulation among scientists or members of those professions or persons so studying or in any publication published by or on behalf of the Crown.
(2) Where the publication of the name of a controlled drug is prohibited under this section in relation to any proceedings every person commits an offence against this Act who, within the said period of 5 years, publishes the name of that drug or any name or particulars likely to lead to the identiﬁcation of that drug as the controlled drug to which reference was made in those proceedings.
(3) Nothing in this section shall be construed to limit the provisions of any other enactment relating to the prohibition or regulation of the publication of reports or particulars relating to any judicial proceedings.
Compare: 1965 No 45 s 20A ; 1970 No 27 s 5 Powers of Minister to prohibit importation, etc, of controlled drugs The Minister may from time to time, by notice in the Gazette, prohibit the importation, manufacture, production, procuring, possession, supply, administration, or other use of any to speciﬁed controlled drug, either absolutely or subject 22 (1) 48 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 22 such conditions as he thinks ﬁt, for any speciﬁed period not exceeding one year: Provided that this power shall not be exercised more than once in respect of any controlled drug so speciﬁed.
(1A) The Minister may from time to time, by notice in the Gazette, prohibit the importation or supply of any class of pipe or other utensil, not being a needle or syringe, that may be used for administering any controlled drug or in the preparation of any controlled drug to be administered, either absolutely or subject to such conditions as the Minister thinks ﬁt.
Every person commits an offence against this Act who,— (a) (2) Being a person permitted by or under this Act to import, manufacture, produce, procure, possess, supply, admin­ ister, or otherwise use, as the case may require, a con­ trolled drug speciﬁed in a notice under subsection (1) ; or (b) Were it not for a notice issued under subsection (1), would be permitted by or under this Act to import, manufacture, produce, procure, possess, supply, admin­ ister, or otherwise use, as the case may require, a con­ trolled drug speciﬁed in that notice,— (3) contravenes or fails to comply with that notice.
Every person commits an offence against this Act who— (a) (b) (c) Supplies a pipe or other utensil whose supply is abso­ lutely prohibited by a notice issued under subsection (1A) ; or Supplies a pipe or other utensil otherwise than in ac­ cordance with any condition under which that pipe or utensil may, under a notice issued under subsection (1A), be supplied; or Imports a pipe or other utensil otherwise than in accord­ ance with any condition under which that pipe or uten­ sil may, under a notice issued under subsection (1A), be imported.
(4) Subject to subsection (5), every person who commits an offence against subsection (3) is liable,— (a) In the case of an individual, to imprisonment for a term not exceeding 3 months or to a ﬁne not exceeding $1,000, or to both; or 49 s 23 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 (b) In the case of a body corporate, to a ﬁne not exceeding $5,000.
(5) Where— (a) A body corporate is convicted of an offence against sub­ section (3) ; and (b) Under section 17(2), a person (being a director or person concerned in the management of that body corporate) is also guilty of that offence,— that person is liable to imprisonment for a term not exceeding 3 months or to a ﬁne not exceeding $5,000, or to both.
Every notice issued under subsection (1A) is a regulation for the purposes of the Regulations (Disallowance) Act 1989, but is not a regulation for the purposes of the Acts and Regulations Publication Act 1989.

Compare: 1960 No 97 s 28 Subsection (1A) was inserted, as from 13 January 1988, by section 4(1) Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193).
Subsection (2) was amended, as from 13 January 1988, by section 4(2) Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193) by inserting the words “, or any pipe or other utensil of a class speciﬁed in a notice under subsection (1A) of this section,”.

Subsection (2) was substituted, as from 21 August 1997, by section 2 Misuse of Drugs Amendment Act 1997 (1997 No 57).

Subsections (3) to (6) were inserted, as from 21 August 1997, by section 2 Misuse of Drugs Amendment Act 1997 (1997 No 57).
Powers of Minister to prohibit prescribing, etc Subject to subsection (2) of this section, the Minister may at any time, by notice in the Gazette,— (a) Prohibit any speciﬁed medical practitioner, dentist, midwife, designated prescriber, or veterinarian from prescribing controlled drugs: (aa) Prohibit any speciﬁed midwife from prescribing pethi­ (b) dine (as described in Schedule 2 to this Act ): Prohibit any speciﬁed person from exercising all or any of the rights conferred by section 8 of this Act, whether those rights are so conferred on persons generally or on a particular class of person to which that person belongs.
The Minister shall not exercise any power conferred on him by subsection (1) of this section — (6) 23 (1) (2) 50 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 23 (a) (b) (c) (ca) (d) (e) In the case of a medical practitioner, except on the rec­ ommendation of the Medical Council of New Zealand; or In the case of a dentist, except on the recommendation of the Dental Council of New Zealand; or In the case of a veterinarian, except on the recommen­ dation of the Veterinary Council of New Zealand; or In the case of a midwife, except on the recommendation of the Nursing Council of New Zealand; or In the case of a pharmacist, except on the recommenda­ tion of the Pharmacy Council; or In the case of any designated prescriber to whom para­ graph (d) does not apply, except on the recommenda­ tion of the Council or Board, speciﬁed in regulations made under this Act, that has jurisdiction in respect of the class of registered health professional to which the designated prescriber belongs.
(3) The Minister may at any time, by notice in the Gazette, revoke any notice given under subsection (1) of this section.
(4) Notwithstanding anything in any other Act, each Council and each Board referred to in subsection (2) of this section shall, for the purpose of considering and determining whether or not to make a recommendation to the Minister under that subsection, have jurisdiction to inquire into any prescribing of or dealing in controlled drugs by a member of the profession with which it is concerned, and any matter incidental thereto, when such prescribing or dealing has been brought or otherwise comes to its attention.
For the purposes of subsection (4), each such Council or Board has and may exercise any powers with respect to summoning witnesses, administering oaths, hearing evidence and other matters of procedure, and with respect to the payment and receiving of costs and expenses, conferred on it or any disciplinary committee or disciplinary tribunal in relation to disciplinary proceedings, by the enactment under which the Council or Board is constituted.
(5) (5A) Despite subsection (5), it is not necessary, unless the Council or Board so requires, for any other body to conduct an 51 s 23 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 investigation or inquiry or to be represented at the inquiry conducted by the Council or Board.
(6) Without prejudice to the liability of any person under any other provision of this Act, every medical practitioner, dentist, midwife, designated prescriber, or veterinarian who prescribes any controlled drug in contravention of a notice under subsection (1) of this section commits an offence against this Act and is liable— (a) To imprisonment for a term not exceeding 6 months or to a ﬁne not exceeding $1,000 or to both, where a Class A controlled drug or a Class B controlled drug was the controlled drug or one of the controlled drugs in relation to which the offence was committed: To imprisonment for a term not exceeding 3 months or to a ﬁne not exceeding $200 or to both, in any other case.
(b) (7) Without prejudice to the liability of any midwife under any other provision of this Act, every midwife who prescribes pethidine (as so described) in contravention of a notice under subsection (1) of this section commits an offence against this Act and is liable to imprisonment for a term not exceeding 6 months or to a ﬁne not exceeding $1,000, or to both.
Compare: SR 1966/82, regs 13(2), 21, 35 as Section 23 was amended, from 22 December 2005, by section 105 Veterinarians Act 2005 (2005 No 126) by substituting the word “veterinarian” for the words “veterinary surgeon” wherever they appear.

Subsection (1)(a) was amended, as from 15 October 1999, by section 16 Medicines Amendment Act 1999 (1999 No 117) by inserting the words “registered midwife, designated prescriber,”, after the word “dentist,”.
Subsection (1)(a) was amended, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48) by omitting the word “registered”.

See sections 178 to 227 of that Act as to the transitional provisions.

Subsection (1)(aa) was inserted, as from 28 August 1990, by section 16(1) Nurses Amendment Act 1990 (1990 No 107).
Subsection (1)(aa) was amended, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48) by omitting the word “registered”.

See sections 178 to 227 of that Act as to the transitional provisions.

Section (2)(c) was amended, as from 22 December 2005, by section 105 Veterinarians Act 2005 (2005 No 126) by substituting the word “Veterinary Council of New Zealand” for the words “Veterinary Surgeons Board”.
52 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 24 Subsection (2)(ca) was inserted, as from 28 August 1990, by section 16(2) Nurses Amendment Act 1990 (1990 No 107).

Subsection (2)(ca) was amended, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48) by omitting the word “registered”.

See sections 178 to 227 of that Act as to the transitional provisions.
Subsection (2)(d) was amended, as from 22 June 2005, by section 15 Misuse of Drugs Amendment Act 2005 (2005 No 81) by substituting the words “Pharmacy Council” for the words “Council of the Pharmaceutical Society of New Zealand”.

Subsection (2)(e) was inserted, as from 15 October 1999, by section 16 Medicines Amendment Act 1999 (1999 No 117).
Subsection (4) was amended, as from 15 October 1999, by section 16 Medicines Amendment Act 1999 (1999 No 117) by substituting the words “each Board” for the words “the Board”.

Subsection (5) was substituted, and subsection (5A) was inserted, as from 15 October 1999, by section 16 Medicines Amendment Act 1999 (1999 No 117).
Subsection (6) was amended, as from 15 October 1999, by section 16 Medicines Amendment Act 1999 (1999 No 117) by inserting the words “registered midwife, designated prescriber,”, after the word “dentist,”.

Subsection (6) was amended, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48) by omitting the word “registered”.

See sections 178 to 227 of that Act as to the transitional provisions.
Subsection (7) was inserted, as from 28 August 1990, by section 16(3) Nurses Amendment Act 1990 (1990 No 107).

Subsection (7) was amended, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48) by omitting the word “registered” in both places it occurred.

See sections 178 to 227 of that Act as to the transitional provisions.
24 (1) commits Treatment of people dependent on controlled drugs Every medical practitioner an offence who prescribes, administers, or supplies a controlled drug for or to a person who the practitioner has reason to believe is dependent on that or any other controlled drug,— (a) in the course or for the purpose of the treatment of the person for dependency; and otherwise than in accordance with subsection (2).
(b) (1A) Every midwife or designated prescriber commits an offence against this Act who prescribes, administers, or supplies a controlled drug for or to a person who the midwife or prescriber has reason to believe is dependent on that or any 53 s 24 (2) Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 other controlled drug, in the course of, or for the purpose of, the treatment of the person for dependency.
In the course or for the purpose of the treatment for dependency of a person who the practitioner has reason to believe is dependent on that or any other controlled drug, a medical practitioner may prescribe, administer, or provide a controlled drug for or to the person if the medical practitioner— (a) is for the time being speciﬁed under subsection (7)(a); or is— (i) (b) working in an institution, clinic, or place for the time being speciﬁed under subsection (7)(b); and for the time being authorised in writing to pre­ scribe controlled drugs by a medical practitioner working in that institution, clinic, or place who is for the time being speciﬁed under subsection (7)(a); and (ii) (c) is— (i) (ii) (d) is acting— (i) (ii) 54 acting in the medical practitioner’s capacity as a medical ofﬁcer employed by a hospital care operator within the meaning of section 58(4) of the Health and Disability Services (Safety) Act 2001 for the time being speciﬁed under subsec­ tion (7)(b); and for the time being authorised in writing by the person in charge of that institution, acting under the general or speciﬁc directions of a Medical Ofﬁcer of Health, to prescribe controlled drugs; or with the permission in writing, given in relation to that particular person, of a medical practitioner for the time being authorised by paragraph (a) or paragraph (b) or paragraph (c) to do so; and during the period, and in accordance with the terms and conditions (if any), speciﬁed or im­ posed in the permission, or in any written modi­ Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 24 ﬁcation of the permission, given by that medical practitioner.
(3) Except with the concurrence of the Medical Ofﬁcer of Health, no permission under subsection (2)(d) may specify a period longer than 3 months.

(4) A permission under subsection (2)(d) may from time to time be renewed by the person who gave it, or any other medical practitioner authorised by that paragraph to give such a permission.
Except with the concurrence of the Medical Ofﬁcer of Health, no renewal under subsection (4) of a permission under subsection (2)(d) may be for a period longer than 3 months.
(5) (6) An authority or permission given or renewed under subsection (2) or subsection (4)— (a) may at any time be withdrawn by the person who gave or renewed it, by written notice to the person to whom it was given; and is deemed to have been withdrawn when, as the case may be,— (i) (b) (ii) (iii) the notice under subsection (7)(a) specifying the medical practitioner by whom the authority or permission was given is revoked; or the notice under subsection (7)(b) specifying the institution, clinic, or place, in respect of which the authority or permission concerned was given or renewed is revoked; or the medical practitioner by whom the authority or permission was given dies, or ceases to work in the premises, clinic, or place to which the au­ thority relates.
(7) The Minister may from time to time, by notice in the Gazette,— (a) specify any medical practitioner (by name) as a medical practitioner who may, subject to any general or speciﬁc conditions imposed by the Minister on the recommen­ dation of the Director­General of Health, prescribe, ad­ minister, or supply controlled drugs for the purposes of this section: 55 s 24 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 (b) specify (by name or description) as a place at which controlled drugs may be prescribed, administered, or supplied for the purposes of this section— (i) any hospital care institution within the mean­ ing of section 58(4) of the Health and Disability Services (Safety) Act 2001; or any clinic, or other place in which a medical prac­ titioner for the time being speciﬁed under para­ graph (a) works.
(ii) The Minister may from time to time, by notice in the Gazette, revoke or amend a notice under subsection (7).
This section does not apply to— (a) the treatment of a patient, within the meaning of the Alcoholism and Drug Addiction Act 1966, while the patient is in an institution, within the meaning of that Act: the emergency treatment of a patient in a hospital care institution within the meaning of section 58(4) of the Health and Disability Services (Safety) Act 2001, for a period not exceeding 3 days: the treatment of any restricted person within the mean­ ing of section 25.
(b) (c) Subsection (1) was amended, as from 13 January 1983, by section 5 Misuse of Drugs Amendment Act 1982 (1982 No 151) by inserting the words “on that or any other controlled drug”.

Subsection (1A) was inserted, as from 15 October 1999, by section 16 Medicines Amendment Act 1999 (1999 No 117).

Subsection (1A) was amended, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48) by omitting the word “registered”.
See sections 178 to 227 of that Act as to the transitional provisions.

Subsection (2)(b) (as amended by section 98 Area Health Boards Act 1983 (1983 No 134)) was amended, as from 1 July 1993, by section 32 Health Reforms (Transitional Provisions) Act 1993 (1993 No 23) by omitting the words “the Area Health Boards Act 1983 or”.
Subsection (2)(c) (as amended by section 98 Area Health Boards Act 1983 (1983 No 134)) was substituted, as from 1 July 1993, by section 32 Health Reforms (Transitional Provisions) Act 1993 (1993 No 23).

Subsection (2) was substituted, as from 15 November 2000, by section 9(1) Misuse of Drugs Amendment Act 2000 (2000 No 47).
(8) (9) 56 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 25 Subsection (3) was amended, as from 15 November 2000, by section 9(2) Misuse of Drugs Amendment Act 2000 (2000 No 47) by substituting the word “approved” for the word “speciﬁed”.
Subsection (5)(b) (as amended by section 98 Area Health Boards Act 1983 (1983 No 134)) was amended, as from 1 July 1993, by section 32 Health Reforms (Transitional Provisions) Act 1993 (1993 No 23) by substituting the words “any person carrying on a hospital licensed pursuant to the Hospitals Act 1957” for the words “an Area Health Board or a Hospital Board”.

Subsection (5) was substituted, as from 15 November 2000, by section 9(3) Misuse of Drugs Amendment Act 2000 (2000 No 47).
Section 24 was substituted, as from 1 October 2002 by section 58(1) Health and Disability Services (Safety) Act 2001 (2001 No 93).

See section 11 of that Act for transitional provisions.

Subsection (1A) was amended, as from 22 October 2003, by section 4(1) Misuse of Drugs Amendment Act 2003 (2003 No 86) by substituting the word “prescriber” for the word “practitioner” in both places where it occurs.
Subsection (7)(a) was amended, as from 22 October 2003, by section 4(2) Misuse of Drugs Amendment Act 2003 (2003 No 86) by inserting the words “, subject to any general or speciﬁc conditions imposed by the Minister on the recommendation of the Director­General of Health,” after the words “who may”.

Restrictions on supply to particular persons In this section restricted person means a person who is the subject of a notice given under subsection (3) of this section and for the time being in force.
Every person commits an offence against this Act who,— (a) In contravention of a notice which has been served on him pursuant to subsection (3) or subsection (4) of this section, or which has otherwise come to his attention, prescribes for or supplies to a restricted person, know­ ing him to be a restricted person, any controlled drug; or (b) Knowing himself to be a restricted person, procures or attempts to procure a prescription or a controlled drug from a person who is for the time being prohibited, by a notice under subsection (3) or subsection (4) of this section, from issuing the prescription or supplying the controlled drug to him.
25 (1) (2) (3) Where a Medical Ofﬁcer of Health is satisﬁed that any person has been obtaining a controlled drug over a prolonged period and is likely to seek further supplies of a controlled drug, or prescriptions for the supply of a controlled drug, he may from 57 s 26 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 time to time, by notice in such form as he thinks ﬁt, given generally or to any person authorised by or under this Act to supply controlled drugs, prohibit every medical practitioner and dentist from issuing prescriptions for the supply of, and every person from supplying, any controlled drugs to the ﬁrst­mentioned person, subject to such exceptions, relating to particular medical practitioners or dentists or sources of supply, or particular controlled drugs, or the frequency or quantity of prescriptions or supply, as may be speciﬁed in the notice.
The Medical Ofﬁcer of Health may at any time by a like notice revoke, or vary, or modify any prohibition, condition, or exception contained in a notice given by him under this section.

(4) (5) A copy of any notice under subsection (3) or subsection (4) of this section shall be served, either personally or by registered post, on the restricted person, but failure to comply with this requirement shall not invalidate the notice.
(6) Any person who is aggrieved by the issue of a notice under this section, or by the refusal of the Medical Ofﬁcer of Health to revoke, vary, or modify, any prohibition, condition, or exception contained in any such notice, may appeal in writing to the Minister whose decision shall be ﬁnal.
Compare: SR 1966/82, regs 13(2), 26 Arrest by Customs Ofﬁcers If any ofﬁcer of Customs has reasonable cause to believe or suspect that any person, in contravention of this Act, has imported into or exported from New Zealand any controlled drug, or has been concerned in such import or export, he may arrest that person without a warrant.
Compare: 1965 No 45 s 14 General penalty Every person who commits an offence against this Act for which no penalty is provided elsewhere than in this section is liable to imprisonment for a term not exceeding 3 months or to a ﬁne not exceeding $500 or to both.
Compare: 1965 No 45 s 15 26 27 58 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 28A 28 (1) Legal proceedings Except where this Act otherwise provides, every offence against this Act or against any regulations made under this Act shall be punishable on summary conviction.
(2) Notwithstanding anything in section 14 of the Summary Proceedings Act 1957, any information in respect of any offence against this Act or against any regulations made under this Act may be laid at any time within 4 years from the time when the matter of the information arose.
(2A) Notwithstanding anything in section 14 of the Summary Proceedings Act 1957 or subsection (2) of this section, any information in respect of any offence against section 6 or section 9 or section 10 of this Act may be laid at any time.

This subsection amended Part 2 of Schedule 1 to the Summary Proceedings Act 1957 (reprinted 1982, RS Vol 9, p 734).

Compare: 1965 No 45 s 16 (3) Subsection (2A) was inserted, as from 7 January 1981, by section 2 Misuse of Drugs Amendment Act 1980 (1980 No 64).
28A Consent of Attorney­General required in proceedings under section 12C (1) No information may be laid for an offence against section 12C except with the consent of the Attorney­General.
(2) A person who is alleged to have committed an offence against section 12C may be arrested, or a warrant for the arrest of the person may be issued and executed, and any such person may be remanded in custody or on bail, even if the Attorney­General’s consent to the laying of the information has not been obtained, but no further or other proceedings may be taken until that consent has been obtained.
The Attorney­General may, before deciding whether or not to give his or her consent under subsection (1), make such inquiries as he or she thinks ﬁt.

This section was inserted, as from 12 May 1998, by section 6 Misuse of Drugs Amendment Act 1998 (1998 No 14).
(3) 59 s 29 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 29 Mistake as to nature of controlled drug or precursor substance Where, in any proceedings for an offence against any of the provisions of section 6 or section 7 or section 12A or section 12AB or section 12AC of this Act, it is necessary, if the defendant is to be convicted of the offence charged, for the prosecution to prove that some substance, preparation, mixture, or article involved in the alleged offence was the controlled drug or precursor substance which the prosecution alleges it to have been, and it is proved that the substance, preparation, mixture, or article was that controlled drug or precursor substance, the defendant shall not be acquitted of the offence charged by reason only of the fact that he did not know or may not have known that the substance, preparation, mixture, or article in question was the particular controlled drug or precursor substance alleged.
Section 29 was amended, as from 12 May 1998, by section 7 Misuse of Drugs Amendment Act 1998 (1998 No 14) by inserting the expression “or section 12A”, and by inserting the words “or precursor substance”.

Section 29 was amended, as from 22 June 2005, by section 16 Misuse of Drugs Amendment Act 2005 (2005 No 81) by inserting the words “or section 12AB or section 12AC” after the expression “section 12A”.
29A Issue of usable quantity (1) On the summary trial of any person charged with an offence against this Act in which it is alleged that the defendant had in his possession any controlled drug in contravention of this Act, it shall not be necessary for the prosecution to prove that the amount of the controlled drug in the defendant’s possession was of a usable quantity, unless the defendant puts the matter in issue.
(2) Where, in the course of a summary trial, the defendant puts in issue the question of whether or not the amount of any controlled drug alleged to have been in his possession was of a usable quantity, the District Court Judge shall, if requested to do so by the prosecutor, adjourn the hearing for such period as he considers sufﬁcient to enable the prosecutor to arrange for the attendance in Court of a witness or witnesses to adduce evidence that that amount was of a usable quantity; and, if the prosecutor has closed his case before the said question is put in 60 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 29C issue, the District Court Judge shall also grant the prosecutor leave to re­open his case for the purpose of adducing evidence that the amount of the drug was of a usable quantity.
This section was inserted, as from 16 October 1978, by section 7 Misuse of Drugs Amendment Act 1978 (1978 No 65).

Subsection (2) was amended, as from 1 April 1980, by substituting the words “District Court Judge” for the word “Magistrate” pursuant to section 18(2) District Courts Amendment Act 1979 (1979 No 125).
29B Special provisions where offence relating to cannabis preparations alleged For the purposes of any proceedings for an offence against any of the provisions of section 6 or section 7 of this Act in relation to any cannabis preparation the following provisions shall apply: (a) (b) (c) (d) It shall be for the prosecution to prove that the prepar­ ation to which the charge relates contains any tetrahy­ drocannabinols: Subject to paragraph (a) of this section, the preparation shall be deemed to have been produced by subjecting cannabis plant material to some kind of processing un­ less it is in a form that is clearly recognisable as plant material: Plant material means the whole or any part of the leaf, ﬂower, or stalk of any plant (of whatever species): The question of whether or not any preparation is in a form that is clearly recognisable as plant material shall, in the event of dispute between the prosecutor and the defendant, be determined by the jury (or, if there is no jury, by the Judge as a question of fact) by means of a visual inspection unaided by any microscope or magni­ fying glass (other than spectacles ordinarily worn) or by any other device.
This section was inserted, as from 13 January 1983, by section 6 Misuse of Drugs Amendment Act 1982 (1982 No 151).
29C Special provisions where offence relating to controlled drug analogues alleged It shall be a defence to a charge relating to the possession of any controlled drug analogue in contravention of any of the 61 s 30 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 provisions of this Act if the defendant proves that he or she had the substance— (a) For some purpose other than— (i) Consuming, smoking, snorting, or injecting by any person, or using in any other manner in­ tended to have a pharmacological effect on the user; and Supplying or administering it to any other per­ son; or (ii) (b) For the purpose of supplying it or administering it to any other person in accordance with any procedure ap­ proved by the Director­General of Health.
This section was inserted, as from 13 January 1988, by section 5 Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193).
Burden of proof Without prejudice to subsection (8) of section 67 of the Summary Proceedings Act 1957, in any proceedings against any person in respect of any offence against this Act or against any regulations made under this Act in which it is proved that he had in his possession any controlled drug, or did any act in relation to a controlled drug which would have amounted to that offence if such act were not done pursuant to section 8 of this Act or to a licence under this Act or as otherwise permitted by regulations under this Act, the burden of proving that he had such controlled drug in his possession, or did such act, pursuant to the said section 8 or to any such licence or as so permitted shall lie on him.
Compare: 1965 No 45 s 17 Evidence of analysis For the purposes of this section, the term analyst means— (a) Any person who is designated by the Minister by notice in the Gazette as the analyst in charge of an approved laboratory; or (b) Any person who works in an approved laboratory and who is authorised, by the analyst in charge of that la­ boratory, to act as an analyst for the purposes of this Act, either generally or in any particular case.
30 31 (1) 62 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 31 (2) Subject to subsections (3) and (4) of this section, in any proceedings for an offence against this Act, a certiﬁcate purporting to be signed by an analyst, and certifying that, on a date stated in the certiﬁcate, the substance, preparation, mixture, or article to which the certiﬁcate relates was received by the signatory personally in any case or (where the substance, preparation, mixture, or article was delivered in a sealed package or by registered post) by any other person (being a person who works in an approved laboratory and who is authorised, by the analyst in charge of that laboratory, to receive it), from the member of the Police or employee of the Police Department or ofﬁcer of Customs named in the certiﬁcate, and that upon analysis that substance, preparation, mixture, or article was found to be or to contain a particular controlled drug or precursor substance (whether of a speciﬁed or an unspeciﬁed weight) or a particular prohibited plant, or a particular part of a particular prohibited plant, or a seed or fruit of a particular prohibited plant, speciﬁed or described in the certiﬁcate, shall until the contrary is proved be sufﬁcient evidence— (a) Of the qualiﬁcations and authority of the person by whom the analysis was carried out; and (b) Of the authority of the person who signed the certiﬁcate to sign that certiﬁcate; and Of the facts stated in the certiﬁcate.
(c) (2A) Where the substance, preparation, mixture, or article was delivered in a sealed package or by registered post and received by any person (not being the person who signed the certiﬁcate but being a person who works in an approved laboratory and who is authorised, by the analyst in charge of that laboratory, to receive it) from any person referred to in subsection (2) of this section,— (a) The person who made the analysis may give evidence of receipt by that other person of the substance, prepar­ ation, mixture, or article that is the subject of the ana­ lysis; and Such evidence shall, in the absence of evidence to the contrary, be admissible as sufﬁcient proof of the proper (b) 63 s 31 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 receipt of the substance, preparation, mixture, or article by the person who made the analysis.
(3) A certiﬁcate referred to in subsection (2) of this section shall be admissible in evidence only if— (a) At least 7 clear days before the hearing at which the cer­ tiﬁcate is tendered, a copy of that certiﬁcate is served, by or on behalf of the prosecutor, on the defendant, and the defendant is at the same time informed in writing that the prosecutor does not propose to call the person who made the analysis as a witness at the hearing; and The defendant does not, by notice in writing given to the prosecutor at least 3 clear days before the hearing, require the person who made the analysis to be called by the prosecutor as a witness at the hearing.
(b) (5) (4) Notwithstanding anything in subsection (3) of this section, a certiﬁcate referred to in subsection (2) of this section shall not be admissible in evidence if the Court, either of its own motion or on the application of the defendant made either before or after the commencement of the hearing, in its discretion directs that the result of the analysis shall be disregarded unless that result is proved by the oral evidence of the person who made the analysis.
In this section— member of the police includes the following persons (a) (b) (c) a member of the Royal New Zealand Naval Police: a member of the New Zealand Army Military Police: a member of the Senior Air Security Specialist trade, or of the Air Security Specialist trade, of the Royal New Zealand Air Force: an ofﬁcer of the Air Security specialisation of the Operational Support Branch of the Royal New Zealand Air Force (d) Served means served in accordance with sections 24 to 29 of the Summary Proceedings Act 1957.
(6) Any notice given by the Minister in the Gazette for the purposes of subsection (1) of this section shall be deemed to be a regulation for the purposes of the Regulations 64 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 32 (Disallowance) Act 1989 and the Acts Interpretation Act 1924.

Subsection (1), was amended, as from 6 November 1986, by section 3 Misuse of Drugs Amendment Act 1986 (1986 No 102), by substituting the word “employee” for the word “ofﬁcer”.
It was substituted, as from 1 July 1992, by section 5(1) Misuse of Drugs Amendment Act 1992 (1992 No 49).
Subsection (2) was substituted, as from 13 January 1988, by section 6(1) Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193) and amended, as from 1 July 1992, by section 5(2) Misuse of Drugs Amendment Act 1992 (1992 No 49) by substituting the words “person (being a person who works in an approved laboratory and who is authorised, by the analyst in charge of that laboratory, to receive it)” for the words “employee of the Department of Scientiﬁc and Industrial Research authorised by the Dominion Analyst to do so”.
Subsection (2) was amended, as from 12 May 1998, by section 8 Misuse of Drugs Amendment Act 1998 (1998 No 14) by inserting the words “or precursor substance”.

Subsection (2A) was inserted, as from 13 January 1988, by section 6(1) Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193) and substituted, as from 1 July 1992, by section 5(3) Misuse of Drugs Amendment Act 1992 (1992 No 49).

Subsection (5) was inserted, as from 7 January 1981, by section 3(2) Misuse of Drugs Amendment Act 1980 (1980 No 64).
Subsection (5) member of the police: this deﬁnition was substituted, as from 22 October 2003, by section 5 Misuse of Drugs Amendment Act 2003 (2003 No 86).

Section 31(5) member of the police paragraph (c): substituted, on 27 March 2008, by section 4 of the Misuse of Drugs Amendment Act 2008 (2008 No 13).

Section 31(5) member of the police paragraph (d): substituted, on 27 March 2008, by section 4 of the Misuse of Drugs Amendment Act 2008 (2008 No 13).
Subsection (6) was inserted, as from 1 July 1992, by section 5(4) Misuse of Drugs Amendment Act 1992 (1992 No 49).

32 (1) Forfeiture Every person convicted of an offence against this Act shall, in addition to any penalty imposed pursuant to this Act, forfeit to Her Majesty, by virtue of such conviction, all articles, if any, in respect of which the offence was committed and in the possession of such person.
(2) Articles forfeited under the provisions of subsection (1) of this section shall be sold, destroyed, or otherwise disposed of as the Minister directs.
If, on the conviction of any person for an offence against section 6 of this Act, the Judge or District Court Judge is satisﬁed that money found in the possession of that person (3) 65 s 32 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 was received by that person in the course of or consequent upon the commission of that offence, or was in the possession of that person for the purpose of facilitating the commission of an offence against that section, the Judge or District Court Judge may, in addition to any other penalty imposed pursuant to this Act, order that that money be forfeited to the Crown.
If, on the conviction of any person for an offence against section 6 of this Act, the Court is satisﬁed that any motor vehicle, aircraft, or ship or boat or other vessel owned by the convicted person (whether solely or as joint tenant or tenant in common with any other person or persons) or in which he has any interest (whether pursuant to a hire purchase agreement, leasing agreement, or otherwise) at the time of his conviction was used by the convicted person in the commission of that offence (whether or not he was the driver or person in charge), the Court shall, unless in the circumstances of the case the Court considers that it would be unjust to do so, order, in addition to any other penalty imposed under this Act, that the motor vehicle, aircraft, or ship or boat or other vessel be forfeited to Her Majesty.
If an order for forfeiture is made under subsection (4), the following provisions of the Sentencing Act 2002 apply, so far as they are applicable and with any necessary or speciﬁc modiﬁcations:— (a) (b) (c) (d) section 127: section 128, except subsection (2): sections 130 to 136: section 137, except that paragraphs (c) and (d) of sub­ section (3) do not apply and, instead, any proceeds of sale remaining after payment in accordance with sub­ section (3)(a) and (b) must be paid into the Crown Bank Account: sections 138 to 142.
(e) Compare: 1965 No 45 s 18 Subsection (3) was amended, as from 1 April 1980, by substituting the words “District Court Judge” for the word “Magistrate” pursuant to section 18(2) District Courts Amendment Act 1979 (1979 No 125).

Subsection (4) was inserted, as from 7 January 1981, by section 4 Misuse of Drugs Amendment Act 1980 (1980 No 64).
(4) (5) 66 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 34 33 Subsection (5) was inserted, as from 7 January 1981, by section 4 Misuse of Drugs Amendment Act 1980 (1980 No 64) and substituted, as from 1 October 1985, by section 150(1) Criminal Justice Act 1985 (1985 No 120).

Subsection (5) was amended, as from 1 July 1989, by substituting the words “Crown Bank Account” for the words “Public Account” pursuant to section 83(1)(a) and (7) Public Finance Act 1989 (1989 No 44).
Subsection (5) was substituted, as from 30 June 2002, by section 186 Sentencing Act 2002 (2002 No 9).

See clause 2 Sentencing Act Commencement Order 2002 (SR 2002/176).

Subsection (5) was substituted, as from 7 July 2004, by section 19 Sentencing Amendment Act 2004 (2004 No 68).
Notiﬁcation of conviction of medical practitioners, etc Where any person being a medical practitioner, pharmacist, dentist, midwife, designated prescriber, or veterinarian is convicted of any offence against this Act or against any the Court shall cause regulations made under this Act, particulars of the conviction to be sent to the person charged with the duty of keeping the register on which the name of the convicted person appears as a medical practitioner, pharmacist, dentist, midwife, designated prescriber, or veterinarian, as the case may be.
Compare: 1965 No 45 s 19 Section 33 was amended, as from 28 August 1990, by section 17 Nurses Amendment Act 1990 (1990 No 107) by inserting the words “registered midwife,”.

Section 33 was amended, as from 15 October 1999, by section 16 Medicines Amendment Act 1999 (1999 No 117) by inserting the words “designated prescriber,”, after the words “registered midwife,”.
Section 33 was amended, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48) by omitting the word “registered” wherever it occurred.

See sections 178 to 227 of that Act as to the transitional provisions.

from 22 December 2005, by section Section 33 was amended, 105 Veterinarians Act 2005 (2005 No 126) by substituting the word “veterinarian” for the words “veterinary surgeon” in both places they appear.
as 34 Protection of persons acting under authority of Act A person who does any act in pursuance or intended pursuance of any of the functions conferred on him by or under this Act shall not be under any civil or criminal liability in respect thereof, whether on the ground of want of jurisdiction, or 67 s 34A Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 mistake of law or fact, or on any other ground, unless he has acted in bad faith or without reasonable care.
Compare: 1965 No 45 s 21 34A Protection of Police ofﬁcers (1) In this section the term undercover ofﬁcer means a member of the Police whose identity is for the time being concealed for the purpose of a particular investigation of any suspected offence against this Act or of any person suspected of such an offence; and includes any other member of the Police who is for the time being directing or assisting that member in the course of that investigation.
(2) No prosecution for an offence against this Act, or against any regulations made under this Act, shall be commenced or continued against any member of the Police in respect of any act committed by him at a time or during a period when he was acting as an undercover ofﬁcer, except with the leave of the Attorney­General.
(3) A certiﬁcate signed by the Commissioner of Police to the effect that, at any speciﬁed time or during any speciﬁed period, the member of the Police named in the certiﬁcate was acting as an undercover ofﬁcer shall, for the purposes of subsection (2) of this section, be conclusive evidence of that fact.

This section was inserted, as from 16 October 1978, by section 9 Misuse of Drugs Amendment Act 1978 (1978 No 65).
Crimes deemed to be included in extradition treaties For the purposes of the Extradition Act 1999 and any Order in Council in force under section 15 or section 104 of that Act,— Each crime described in section 6 or section 9, includ­ (a) ing— (i) Attempting or conspiring to commit that crime; or (ii) Aiding, abetting, inciting, counselling, or procur­ ing any person to commit that crime; and Each crime described in section 10,— (b) if not already described in the treaty, is deemed to be an offence described in any extradition treaty referred to in subsection (2).
35 (1) 68 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 35A (2) (3) (4) (5) Subsection (1) applies to any treaty concluded before June 1977 and for the time being in force between New Zealand and any country which is a party to the Single Convention on Narcotic Drugs 1961, as amended by the Protocol amending that Convention, done at Geneva on 25 March 1972, or to the Convention on Psychotropic Substances 1971.
If under subsection (1) a crime is deemed to be an offence described in an extradition treaty, a person may be surrendered in accordance with the provisions of the Extradition Act 1999 for that crime even if the act or omission occurred before the date on which the crime was deemed to be an offence described in the extradition treaty.
Subsection (3) does not apply in respect of an act or omission that, had it occurred within the jurisdiction of New Zealand, would not at that time have constituted an offence under New Zealand law.
For the purposes of this section, country includes any territory for whose international relations the government of a country is responsible and to which the extradition treaty and the Single Convention on Narcotic Drugs as amended by the Protocol amending that Convention or, as the case may be, the Convention on Psychotropic Substances, extends.
Subsection (1) of the original section 35 was amended, as from 16 March 1999, by section 9 Misuse of Drugs Amendment Act 1998 (1998 No 14) by omitting the words “A certiﬁcate given under the hand of the Minister of Foreign Affairs that any foreign country is a party as aforesaid shall be sufﬁcient evidence of that fact.” See clause 2 Misuse of Drugs Amendment Act 1998 Commencement Order 1999 (SR 1999/13).
Section 35 was substituted, as from 1 September 1999, by section 111 Extradition Act 1999 (1999 No 55).
35A Further provision on crimes to be treated as included in (1) extradition treaties For the purposes of the Extradition Act 1999 and any Order in Council in force under section 15 or section 104 of that Act, every offence described in any of sections 6, 9, 12A, 12AB, 12B, and 12C (including attempting or conspiring to commit that offence, aiding, abetting, inciting, counselling, or procuring any person to commit that offence) and every offence described in section 10, if not already described in 69 s 35A Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 the treaty, is to be treated as being an offence described in any extradition treaty concluded before the commencement of this section and for the time being in force between New Zealand and any foreign country which is a party to the Vienna Convention.
(3) (2) When subsection (1) requires any offence to be treated as being an offence described in an extradition treaty, a person whose surrender is sought under the Extradition Act 1999 in respect of an act or omission which amounts to that offence is liable to be surrendered in accordance with the provisions of that Act, whether the act or omission occurred before or after the date on which the offence became, by virtue of subsection (1), an offence described in the extradition treaty.
This section does not apply in respect of an act or omission that, had it occurred within the jurisdiction of New Zealand, would not at that time have constituted an offence under New Zealand law.

For the purposes of this section, foreign country includes any territory for whose international relations the Government of a foreign country is responsible and to which the extradition treaty and the Vienna Convention extend.
Sections 35A to 35D were inserted, as from 16 March 1999, by section 10 Misuse of Drugs Amendment Act 1998 (1998 No 14).

See clause 2 Misuse of Drugs Amendment Act 1998 Commencement Order 1999 (SR 1999/13).
(4) Subsection (1) was amended, as from 1 September 1999, by section 111 Extradition Act 1999 (1999 No 55) by substituting the words “Extradition Act 1999 and any Order in Council in force under section 15 or section 104 of that Act,” for the words “Extradition Act 1965 and every Order in Council made under section 3 of that Act or referred to in section 21 of that Act,”.
Subsection (1) was amended, as from 22 June 2005, by section 17 Misuse of Drugs Amendment Act 2005 (2005 No 81) by inserting the expression “12AB,” after the expression “12A,”.

Subsection (2) was amended, as from 1 September 1999, by section 111 Extradition Act 1999 (1999 No 55) by substituting the words “Extradition Act 1999” for the words “Extradition Act 1965”.

Subsection (3) was substituted, as from 1 September 1999, by section 111 Extradition Act 1999 (1999 No 55).
70 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 35D 35B Surrender of offenders [Repealed] Sections 35A to 35D were inserted, as from 16 March 1999, by section 10 Misuse of Drugs Amendment Act 1998 (1998 No 14).

See clause 2 Misuse of Drugs Amendment Act 1998 Commencement Order 1999 (SR 1999/13).

Section 35B was repealed, 111 Extradition Act 1999 (1999 No 55).
as from 1 September 1999, by section 35C Restrictions on surrender of offenders (1) Without limiting the grounds on which surrender must or may be refused under the Extradition Act 1999, but subject to subsection (2), no Court in New Zealand may order the surrender, or the detention for the purposes of surrender, of a person to another country in respect of any act or omission that amounts to an offence described in any of sections 6, 9, 10, 12A, 12AB, 12B, and 12C if the Attorney­General certiﬁes that the case is being or is about to be considered to determine whether or not proceedings should be brought in New Zealand against that person in respect of the act or omission.
If, is in any case to which subsection (1) applies, subsequently determined that proceedings should not be brought in New Zealand against the person in respect of the act or omission, the Attorney­General must advise the Court accordingly, and the Court must proceed with the matter as if the Attorney­General’s certiﬁcate had never been given.

Sections 35A to 35D were inserted, as from 16 March 1999, by section 10 Misuse of Drugs Amendment Act 1998 (1998 No 14).
See clause 2 Misuse of Drugs Amendment Act 1998 Commencement Order 1999 (SR 1999/13).

(2) it Section 35C was substituted, as from 1 September 1999, by section 111 Extradition Act 1999 (1999 No 55).

Subsection (1) was amended, as from 22 June 2005, by section 18 Misuse of Drugs Amendment Act 2005 (2005 No 81) by inserting the expression “12AB,” after the expression “12A,”.
35D Evidence For any purpose in connection with this Act, a certiﬁcate, given by the Secretary of Foreign Affairs and Trade certifying— (a) That any country is or is not, or was or was not at any material time, a party to— 71 s 36 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 (i) (ii) The Single Convention on Narcotic Drugs 1961, as amended by the Protocol amending that Con­ vention, done at Geneva on 25 March 1972; or The Convention on Psychotropic Substances 1971; or (iii) The Vienna Convention; or That the Government of any country is or is not, or was or was not, at any material time, responsible for the international relations of any territory,— (b) is sufﬁcient evidence of that fact.
Sections 35A to 35D were inserted, as from 16 March 1999, by section 10 Misuse of Drugs Amendment Act 1998 (1998 No 14).

See clause 2 Misuse of Drugs Amendment Act 1998 Commencement Order 1999 (SR 1999/13).
Application of Customs and Excise Act 1996 Sections 137, 139, 140, 143 to 145, 148 to 149B, 149C(1) and (2), 149D, 151, 152, 161, 165 to 172, 225, and 226 of the Customs and Excise Act 1996 apply in relation to the controlled drugs and precursor substances referred to in subsection (2) as if they were prohibited imports or exports under that Act.
The controlled drugs and precursor substances are— (a) any controlled drug, other than a controlled drug speci­ ﬁed or described in Part 6 of Schedule 3; and any precursor substance speciﬁed or described in Schedule 4.

(b) The original section 36 was amended, as from 2 September 1996, by section 5 Misuse of Drugs Amendment Act 1996 (1996 No 133) by omitting the words “Part 4, Part 5, or”.

Section 36 was substituted, as from 1 October 1996, by section 289(1) Customs and Excise Act 1996 (1996 No 27).
Section 36 was amended, as from 12 May 1998, by section 11 Misuse of Drugs Amendment Act 1998 (1998 No 14) by omitting the expression “Part 4, Part 5, or”.

Section 36 was amended, as from 9 October 2002, by section 47(4)(a) Customs and Excise Amendment Act 2004 (2004 No 55) by substituting the expression “149A, 149B, 149C(1) and (2), 149D,” for the expression “149”.

Section 36 was substituted, as from 22 June 2005, by section 19 Misuse of Drugs Amendment Act 2005 (2005 No 81).
36 (1) (2) 72 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 37 37 (1) Regulations The Governor­General may from time to time, by Order in Council, make regulations for all or any of the following purposes: (a) Providing for the issue of licences for the import, ex­ port, possession, production, manufacture, procuring, supply, administration, or use of controlled drugs and the cultivation of prohibited plants: Prescribing the form, duration, terms, and conditions of any licence under this Act and enabling additional conditions to be imposed: Prescribing the fees payable for licences under this Act and providing for the cancellation and suspension of such licences: Permitting the import, export, possession, production, manufacture, procuring, supply, administration, or use of controlled drugs, and the cultivation of prohibited plants, otherwise than pursuant to a licence under this Act but subject to such conditions or restrictions as may be prescribed by or imposed under the regulations: Prohibiting, limiting, restricting, and imposing condi­ tions on, either generally or in relation to particular cases or classes of case or particular classes of per­ son, the prescribing, production, manufacture, procur­ ing, supply, use, or possession of controlled drugs pur­ suant to any provision of section 8 of this Act: Requiring persons who are engaged in the import, ex­ port, production, manufacture, procuring, supply, or ad­ ministration of any controlled drug, or who utilise any controlled drug in the course of or in connection with their profession, trade, or calling, or any occupation whether paid or unpaid, or who otherwise undertake the supply or administration of any controlled drug, to keep records in such form and manner and to furnish information with respect to such matters as may be pre­ scribed: regulating the issue of standing orders that authorise the supply and administration of controlled drugs, im­ posing conditions, limitations, requirements, or restric­ (b) (c) (d) (e) (f) (fa) 73 s 37 Misuse
 of Drugs Act 1975 Reprinted as at 1 April 2008 (g) tions in relation to the contents of standing orders of that kind and their use, and providing for any other matters that are necessary or desirable for the administration of standing orders of that kind: Regulating the issue by medical practitioners, dentists, midwives, designated prescribers, and veterinarians of prescriptions for the supply of any controlled drug, and requiring persons issuing or dispensing prescriptions in respect of any such drug to furnish such information relating to those prescriptions as may be prescribed: (ga) Prescribing the circumstances in which, and the condi­ tions under which, any person or class of persons may possess needles or syringes notwithstanding that those needles or syringes may be intended to be used for the purpose of the commission of offences against this Act: (gb) Regulating the sale, exchange, or supply of needles or syringes— (i) (ii) By medical practitioners or pharmacists gener­ ally, or by those approved for the purpose by the Director­General of Health; or By authorised representatives of any agency, as­ sociation, or body approved for the purpose by the Director­General of Health,— notwithstanding that those needles or syringes may be intended by the persons to whom they are sold or sup­ plied, or with whom they are exchanged, to be used for the commission of offences against this Act: Requiring any medical practitioner who attends a per­ son whom he considers, or has reasonable grounds to suspect, is dependent on controlled drugs of any de­ scription to furnish such particulars with respect to that person as may be prescribed: Prohibiting, regulating, or restricting the supply of con­ trolled drugs to any person so dependent and the issue of prescriptions for such supply: Regulating the dispensing and compounding of con­ trolled drugs: Regulating the packing, labelling, storage, carriage, and destruction of controlled drugs: (h) (i) (j) (k) 74 Reprinted as at
 1 April 2008 Misuse of Drugs Act 1975 s 37 (o) (n) (q) (p) Declaring plants to be prohibited plants: (l) (m) Controlling or restricting the cultivation and destruction of prohibited plants and the sale, distribution, posses­ sion, and destruction of the seeds or fruit of prohibited plants: Providing for the weighing, counting, measuring, seal­ ing, seizing, and taking of samples of controlled drugs: Prohibiting, regulating, or restricting advertisements for controlled drugs, and statements made in any such ad­ vertisement: Providing for the waiver of fees in whole or in part in particular cases or classes of cases and for the total or partial refund of fees: Prescribing offences in respect of the contravention of or non­compliance with any regulations made under this Act, and the amounts of ﬁnes that may be imposed in respect of any such offences, which ﬁnes shall be an amount not exceeding $500 and, where the offence is a continuing one, a further amount not exceeding $20 for every day or part of a day during which the offence has continued: Exempting, or providing for the exemption of, any per­ sons or classes of persons, or excepting any controlled drugs, from any provision of any regulation made under this Act which imposes conditions or obligations: Generally for prohibiting, controlling, or restricting the import, export, possession, production, manufacture, procuring, supply, administration, and use of controlled drugs: Providing for such matters as are contemplated by or necessary for giving full effect to the provisions of this Act and for its due administration.
(s) (r) (t) (2) Any regulations made under subsection (1) of this section may— (a) Be expressed to apply to controlled drugs generally, or to particular controlled drugs or classes of controlled drugs speciﬁed or described in the regulations, and may make different provision for different controlled drugs or classes of controlled drugs so speciﬁed or described: 75 s 38 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 (b) Provide for depriving persons of any rights, privileges, or exemptions, conferred on any class of person to which those persons belong, by any such regulations.
Compare: 1965 No 45 s 23 ; 1960 No 97 s 53(2)(h), (o) ; Misuse of Drugs Act 1971, s 10(2)(g), (h), (i) (UK) Subsection (1)(fa) was inserted, as from 22 October 2003, by section 6 Misuse of Drugs Amendment Act 2003 (2003 No 86).

Subsection (1)(g) was amended, as from 28 August 1990, by section 18 Nurses Amendment Act 1990 (1990 No 107) by inserting the words “registered midwives,”.
Subsection (1)(g) was amended, as from 15 October 1999, by section 16 Medicines Amendment Act 1999 (1999 No 117) by inserting the words “designated prescribers,”, after the words “registered midwives,”.

Subsection (1)(g) was amended, as from 18 September 2004, by section 175(1) Health Practitioners Competence Assurance Act 2003 (2003 No 48) by omitting the word “registered”.

See sections 178 to 227 of that Act as to the transitional provisions.
Subsection (1)(g) was amended, as from 22 December 2005, by section 105 Veterinarians Act 2005 (2005 No 126) by substituting the word “veterinarians” for the words “veterinary surgeons”.

Subsection (1)(ga) and (gb) was inserted, as from 13 January 1988, by section 7 Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193).

38 Effect on Poisons Act 1960 [Repealed] Section 38 was repealed, as from 2 July 2001, by section 149 Hazardous Substances and New Organisms Act 1996 (1996 No 30).
See Parts 11 to 16 (comprising sections 151 to 259) of that Act as to the transitional provisions.

See clause 2 Hazardous Substances and New Organisms Act Commencement Order (No 2) 2001 (SR 2001/171).

See section 115 Medicines Act 1981 (1981 No 118) for repeal of the Poisons Act 1960, as from 1 August 1984 39 (1) Repeals The Narcotics Act 1965 and the Narcotics Amendment Act 1970 are hereby repealed.
(2) Any reference in any enactment or in any document to a narcotic within the meaning of the Narcotics Act 1965 shall hereafter, unless the context otherwise requires, be read as a reference to a controlled drug within the meaning of this Act.

Revocations The following Orders in Council are hereby revoked, namely: (a) The Narcotics Order 1966: 40 76 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 s 41 (b) (c) (d) The Narcotics Order 1967: The Narcotics Order (No 2) 1967: The Narcotics Order 1968.
41 Application to Niue Whereas in accordance with Article 36 of the Constitution of Niue (as set out in Schedule 2 to the Niue Constitution Act 1974) the Niue Assembly has by resolution requested and consented to the enactment of a provision extending the provisions of this Act to Niue as part of the law of Niue: Be it therefore enacted as follows: The Niue Act 1966 is hereby amended by inserting, after section 689, the following section: “689A Misuse of Drugs Act in force in Niue “(1) Subject to subsection (2) of this section and to the provisions of this Act, the Misuse of Drugs Act 1975 (so far as it is applicable) shall extend to and be in force in Niue.
In the application of the Misuse of Drugs Act 1975 to Niue, unless the context otherwise requires,— “(a) Every reference in that Act to New Zealand shall be read “(2) as a reference to Niue: “(b) Every reference in section 35 of that Act to an extradition treaty for the time being in force between New Zealand and any foreign country which is a party to the Single Convention on Narcotic Drugs 1961, as amended by the Protocol amending that Convention done at Geneva on 25 March 1972, or to the Convention on Psychotropic Substances 1971, shall be read as a reference to an extradition treaty for the time being in force between New Zealand and any such foreign country which extends to Niue: “(c) Every reference in that Act to the Court, or to a Judge, or to a District Court Judge or Justice, shall be read as a reference to the High Court of Niue or a Judge of that Court or a Commissioner of the Court: “(d) Every reference in that Act to the Minister of Health shall be read as a reference to the Minister in charge of Health in Niue acting with the concurrence of the Chief Medical Ofﬁcer of Niue: 77 Schedule 1 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 “(e) Every reference in that Act to the Medical Ofﬁcer of Health shall be read as a reference to the Chief Medical Ofﬁcer of Niue: “(f) Every reference in that Act to a constable or a member of the Police shall be read as a reference to an ofﬁcer of police of the Niue Public Service: “(g) The references in section 6 of that Act to subsection (2) of section 44 of the Criminal Justice Act 1954 shall be read as references to section 240 of the Niue Act 1966: “(h) The references in section 18 of that Act to section 198 of the Summary Proceedings Act 1957 shall be read as references to section 284 of the Niue Act 1966: “(i) The references in section 39 to the repeal of the Narcotics Act 1965 and the Narcotics Amendment Act 1970 shall be read as a reference to the repeal in Niue of the Narcotics Act 1965 and the Narcotics Amendment Act 1970.” 1 Schedule 1 Class A controlled drugs Section 2(1) The following substances, namely: •• ACETORPHINE (R)­hydroxy­1­methyl­butyl]­06­methyl­6,14­endo ethenomorphine).
(03­acetyl­7,8­dihydro­7 α ­[1 (hexahydro­3a,7a­dimethyl­4,7­ BUFOTENINE (3­(2­dimethylaminoethyl)­5­hydrox­ yindole).

CANTHARIDIN epoxyisobenzofuran­1,3­dione).

COCAINE (methyl ester of benzoylecgonine), except when contained in a Class C controlled drug:** DESOMORPHINE (dihydrodeoxymorphine).

DET (N, N­diethyltryptamine).

DMA (2­amino­1­(2,5­dimethoxyphenyl) propane).


•• •• •• •• •• •• •• •• 78 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 Schedule 1 •• •• •• •• •• •• •• •• •• •• •• •• •• •• •• •• •• •• •• •• 5­dimethoxyphenyl) DMHP (3­(1,2­dimethylheptyl)­1­hydroxy­7, 8, 9, 10­tetrahydro­6, 6, 9­trimethyl­6 H­dibenzo[b, d] pyran).

DMT (N, N­dimethyltryptamine).

DOB (2­amino­1­(4­bromo­2, propane) (also known as bromo­DMA).
ETORPHINE (7,8­dihydro­7 α ­[1 (R)­hydroxy­1­ methylbutyl]­06­methyl­6,14­endo ethenomorphine).

HEROIN (diacetylmorphine).

KETOBEMIDONE methyl­4­propionylpiperidine).

LYSERGIC ACID (essential precursor for manufacture of LSD).

LYSERGIDE (N, N­diethyllysergamide or lysergic acid diethylamide).

MDA propane).

MESCALINE (3,4,5­trimethoxyphenethylamine).

METHAMPHETAMINE (2­methylamino­1­phenyl­ propane).


(2­amino­1­(3,4­methylenedioxyphenyl) (4­meta­hydroxyphenyl­1­ 5­METHOXYDIMETHYLTRYPTAMINE (5­methoxy­N, N­dimethyl­tryptamine).

2­METHOXY­4, 5­METHYLENEDIOXYAM­ PHETAMINE (2­amino­1­(2­methoxy­4, 5­methylene­ dioxyphenyl) propane) (also known as MMDA or MMDA­2).

3­METHOXY­4, 5­METHYLENEDIOXYAM­ PHETAMINE (2­amino­1­(3­methoxy­4, 5­methylene­ dioxyphenyl) propane) (also known as MMDA).

MPTP dine).
MPTP dine).

** PARAHEXYL (3­hexyl­1­hydroxy­7,8,9,10­tetrahy­ dro­6,6,9­trimethyl­6H­dibenzo [b, d] pyran).

PCE (N­ethyl­1­phenylcyclohexylamine).

PCPY 1­(1­phenylcyclohexyl) pyrrolidine).

*** PHP 1­(1­phenylcyclohexyl) pyrrolidine).

*** (1­methyl­4­phenyl­1,2,5,6­tetrahydropyri­ 79 Schedule 1 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 •• •• •• •• •• •• •• •• (1­(2­phenylethyl)­4­phenyl­1,2,5,6­tetrahy­ PEPTP dropyridine).

** PHENCYCLIDINE (1­(1­phenylcyclohexyl) piperi­ dine).
PIPERIDYL BENZILATES (N­methylpiperidyl benzi­ lates and N­ethylpiperidyl benzilates but excluding the methobromide salts).

PMA (2­amino­1­(4­methoxyphenyl) propane).

PSILOCINE (3­(2­dimethylaminoethyl)­4­hydroxyin­ dole).

PSILOTSIN (3­(2­dimethylaminoethyl)­4­hydroxyin­ dole).

PSILOCYBINE (3­(2­dimethylaminoethyl) indol­4­yl dihydrogen phosphate).

STP,DOM phenylpropane).

TCP (1­[1­(2­thienyl) cyclohexyl] piperidine).


*** (2­amino­1­(2,5­dimethoxy­4­methyl) •• •• THALIDOMIDE (α ­phthalimidoglutarimide).

•• •• TMA (2­amino­1­(3, 4, 5­trimethoxyphenyl) propane).
Clause 1 was amended, as from 2 September 1996, by section 6(1) Misuse of Drugs Amendment Act 1996 (1996 No 133) by omitting items relating to 4­BROMO­2, 5­DIMETHOXYAMPHETAMINE (2­amino­1­(4­bromo­2, 5­dimethoxyphenyl) 5­DIMETHOXYAMPHETAMINE; 2, 4­METHOXYAMPHETAMINE; TETRAHYDROCANNABINOLS; 3, 4, 5­TRIMETHOXYAMPHETAMINE.
propane); Clause 1 was amended, as from 2 September 1996, by section 6(2) Misuse of Drugs Amendment Act 1996 (1996 No 133) by substituting the item relating 5­METHYLENEDIOXYAMPHETAMINE (2­amino­1­(3­methoxy­4, 5­methylenedioxyphenyl) propane) (also known as MMDA) for the item relating to 3­METHOXY­4, 5­METHYLENE­ DIOXYAMPHETAMINE.
3­METHOXY­4, to Clause 1 was amended, as from 2 September 1996, by section 6(3) Mis­ use of Drugs Amendment Act 1996 (1996 No 133) by inserting the items relating to DMA (2­amino­1­(2, 5­dimethoxyphenyl) propane); DOB (also known as 5­dimethoxyphenyl) propane) (2­amino­1­(4­bromo­2, bromo­DMA); LYSERGIC ACID (essential precursor for manufacture of LSD), 5­METHYLENEDIOXYAMPHETAMINE (2­amino­1­(2­methoxy­4, 5­methylenedioxyphenyl) propane) (also known as MMDA or MMDA­2); PMA (2­amino­1­(4­methoxyphenyl) propane); TMA (2­amino­1­(3, 4, 5­trimethoxyphenyl) propane).
2­METHOXY­4, Clause 1 was amended, as from 30 May 2003, by clause 4 Misuse of Drugs (Changes to Controlled Drugs) Order 2003 (SR 2003/47) by inserting the item 80 2 3 4 5 1 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 Schedule 2 relating to “METHAMPHETAMINE (2­methylamino­1­phenylpropane)” after the item relating to “MESCALINE”.

See clause 2 Misuse of Drugs (Changes to Controlled Drugs) Order Commencement Order 2003 (SR 2003/116).
The isomers of the substances mentioned in this Schedule whenever the existence of such isomers is possible within the speciﬁc chemical designation.

The esters and ethers of the substances mentioned in this Schedule and the esters and ethers of the isomers mentioned in clause 2 of this Schedule whenever the existence of such esters or ethers is possible.
The salts of the substances mentioned in this Schedule and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3 of this Schedule.

Substances containing any proportion of a substance men­ tioned in clause 1, clause 2, clause 3, or clause 4 of this Schedule.

Schedule 2 Class B controlled drugs Section 2(1) 1 The following substances, namely: • • AMPHETAMINE (2­amino­1­phenylpropane).
CANNABIS preparations: that is, any preparation con­ taining any tetrahydrocannabinols, including cannabis resin (commonly know as hashish) and cannabis oil (commonly known as hash oil), produced by subject­ ing cannabis plant material to any kind of processing.

• • METHCATHINONE.

81 Schedule 2 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 1—continued • • • • (2­methylamino­1­(3,4­methylene­ MDMA dioxyphenyl) propane).

MORPHINE.

OPIUM.
MORPHINE.

OPIUM.

TETRAHYDROCANNABINOLS, except when con­ tained in a Class C controlled drug.

Part 1 was amended, as from 9 September 2005, by clause 4(1) Misuse of Drugs (Changes to Controlled Drugs) Order 2005 (SR 2005/175) by inserting the items “AMPHETAMINE” and “MDMA”.

See clause 2 Misuse of Drugs (Changes to Controlled Drugs) Order Commencement Order 2005 (SR 2005/229).

In Part 1 the item “CANNABIS” was substituted by section 7 Misuse of Drugs Amendment Act 1982 (1982 No 151).
Part 1 clause 1 was amended, as from 13 January 1988, by section 9(1) Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193) by omitting the item relating to “Cocaine”.

Part 1 clause 1 was amended, as from 2 September 1996, by section 7(1) Misuse of Drugs Amendment Act 1996 (1996 No 133) by inserting the item relating to TETRAHYDROCANNABINOLS.
Part 1 clause 1 was amended, as from 30 May 2003, by clause 5(1) Misuse of Drugs (Changes to Controlled Drugs) Order 2003 (SR 2003/47) by in­ serting the item relating to “METHCATHINONE.”.

See clause 2 Misuse of Drugs (Changes to Controlled Drugs) Order Commencement Order 2003 (SR 2003/116).

The isomers of the substances mentioned in clause 1 of this Part of this Schedule whenever the existence of such isomers is possible within the speciﬁc chemical designation.
Part 1 clause 2 was amended, as from 31 May 2002, by clause 3(2)(a) Misuse of Drugs (Classiﬁcation of Fantasy) Order 2001 (SR 2001/383), by inserting the words “clause 1 of” after the words “isomers of the substances mentioned in”.

See also Misuse of Drugs (Classiﬁcation of Fantasy) Order Commencement Order 2002 (SR 2002/111).
The esters and ethers of the substances mentioned in clause 1 of this Part of this Schedule and the esters and ethers of the isomers mentioned in clause 2 of this Part of this Schedule whenever the existence of such esters or ethers is possible.

Part 1 clause 3 was amended, as from 31 May 2002, by clause 3(2)(b) Misuse of Drugs (Classiﬁcation of Fantasy) Order 2001 (SR 2001/383), by inserting the words “clause 1 of” after the words “ethers of the substances mentioned in”.
2 3 82 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 Schedule 2 1—continued See also Misuse of Drugs (Classiﬁcation of Fantasy) Order Commencement Order 2002 (SR 2002/111).

The salts of the substances mentioned in clause 1 of this Part of this Schedule and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3 of this Part of this Schedule.
Part 1 clause 4 was amended, as from 31 May 2002, by clause 3(2)(c) Misuse of Drugs (Classiﬁcation of Fantasy) Order 2001 (SR 2001/383), by inserting the words “clause 1 of” after the words “salts of the substances mentioned in”.

See also Misuse of Drugs (Classiﬁcation of Fantasy) Order Commencement Order 2002 (SR 2002/111).

Substances containing any proportion of a substance men­ tioned in clause 1, clause 2, clause 3, or clause 4 of this Part of this Schedule.
4 5 6 The substance gamma­hydroxybutyrate (GHB) (commonly known as fantasy) and— (a) (b) the esters, ethers, and amides of GHB; and all substances from which GHB can be derived, includ­ ing (without limitation)— 1,4­butanediol: (i) gamma­aminobutyric acid: (ii) gamma­butyrolactone: (iii) gamma­hydroxybutyraldehyde; and (iv) the salts of GHB (including sodium oxybate) and the salts of any substance referred to in paragraph (a) or paragraph (b); and any substance, preparation, or mixture containing any proportion of GHB or any substance referred to in any of paragraphs (a) to (c).
(c) (d) Part 1 clause 6 was inserted, as from 31 May 2002, by clause 3(1) Misuse of Drugs (Classiﬁcation of Fantasy) Order 2001 (SR 2001/383).

See also Misuse of Drugs (Classiﬁcation of Fantasy) Order Commencement Order 2002 (SR 2002/111).

83 Schedule 2 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 1 2 The following substances, namely: • • (2­amino­1­(2,5­dimethoxy­4­ethylphenyl) BENZPHETAMINE (2­benzylmethylamino­1­phenyl­ propane).

CATHINONE (2­amino­1­phenylpropan­1­one).

DOET propane).
DOET propane).

FENCAMFAMINE clo[2.2.1]heptan­2­amine).

FENETHYLLINE (3,7­dihydro­1,3­dimethyl­7­[2­[(1­ methyl­2­ phenylethyl)­amino]ethyl]­1H­purine­2,6­ dione).

FENPROPOREX (2­(2­cyanoethylamino)­1­phenyl­ propane).

(N­ethyl­3­phenylbicy­ MEFENOREX (2­(3­chloropropylamino)­1­phenyl­ propane).

METHAQUALONE (2­methyl­3­(2­methylphenyl)­ 4(3H)­quinazolinone).

4­METHYLAMINOREX (cis ­2­amino­4­methyl­5­ phenyl­2­oxazoline.

METHYLPHENIDATE (α­phenyl­2­piperidineacetic acid methyl ester).
4­METHYLTHIOAMPHETAMINE.

N­ETHYL MDA (2­ethylamino­1­(3, 4­methylene­ dioxyphenyl) propane).

N­ETHYLAMPHETAMINE (2­ethylamino­1­phenyl­ propane).

N­HYDROXY 4­methylenedioxyphenyl) propane).

NORPSEUDOEPHEDRINE (threo ­2­amino­1­hy­ droxy­1­phenylpropane), including cathine.

(2­hydroxyamino­1­(3, MDA • • • • • • • • • • • • • • • • 84 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 Schedule 2 2—continued • • PROPYLHEXEDRINE laminopropane).
PYROVALERONE (1­(4­methylphenyl)­2­(1­pyrro­ lidinyl)­1­pentanone).

(1­cyclohexyl­2­methy­ Part 2 was amended, as from 9 September 2005, by clause 4(2) Misuse of Drugs (Changes to Controlled Drugs) Order 2005 (SR 2005/175) by omitting the items “AMPHETAMINE (2­amino­1­phenylpropane).” and “MDMA (2­methylamino­1­(3,4­methylenedioxyphenyl) propane).”.

See clause 2 Misuse of Drugs (Changes to Controlled Drugs) Order Commencement Order 2005 (SR 2005/229).
Part 2 clause 1 was substituted, as from 13 January 1988, by section 9(2) Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193).

Part 2 clause 1 was amended, as from 13 January 1988, by section 9(2) Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193) by substituting the item relating to “NORPSEUDOEPHEDRINE”.
Part 2 clause 1 was amended, as from 13 January 1988, by section 9(3) Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193) by inserting the items relat­ ing to “4­METHYLAMINOREX; N­ETHYL MDA; N­HYDROXY MDA”.

Part 2 clause 1 was amended, as from 30 May 2003, by clause 5(2) Misuse of Drugs (Changes to Controlled Drugs) Order 2003 (SR 2003/47) by omit­ ting the item relating to “METHAMPHETAMINE”.

See clause 2 Misuse of Drugs (Changes to Controlled Drugs) Order Commencement Order 2003 (SR 2003/116).
Part 2 clause 1 was amended, as from 30 May 2003, by clause 5(3) Misuse of Drugs (Changes to Controlled Drugs) Order 2003 (SR 2003/47) by inserting the item relating to “4­METHYLTHIOAMPHETAMINE.” after the item relat­ ing to “METHYLPHENIDATE”.

See clause 2 Misuse of Drugs (Changes to Controlled Drugs) Order Commencement Order 2003 (SR 2003/116).

The isomers of the substances mentioned in this Part of this Schedule whenever the existence of such isomers is possible within the speciﬁc chemical designation.
The esters and ethers of the substances mentioned in this Part of this Schedule and the esters and ethers of the isomers men­ tioned in clause 2 of this Part of this Schedule whenever the existence of such esters or ethers is possible.

The salts of the substances mentioned in this Part of this Schedule and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3 of this Part of this Schedule.
85 2 3 4 Schedule 2 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 2—continued Substances containing any proportion of a substance men­ tioned in clause 1, clause 2, clause 3, or clause 4 of this Part of this Schedule.

3 5 1 • • • • • (N­[1­(α­ (α­3­acetoxy­6­ (3­acetoxy­6­dimethy­ The following substances, namely: ACETYLMETHADOL • lamino­4,4­diphenylheptane).

ACETYL­α­METHYLFENTANYL methylphenethyl]­4­piperidyl] acetanilide).
ALFENTANIL (N ­[1­[2­(4­ethyl­4,5­dihydro­5­oxo­1 H­(tetrazol­ 1­yl)ethyl]­4­(methoxymethyl)­4­ piperidinyl]­N ­phenylpropanamide).

* ALLYLPRODINE (3­allyl­1­methyl­4­phenyl­4­pro­ pionoxypiperidine).

ALPHACETYLMETHADOL dimethylamino­4,4­diphenylheptane).

ALPHAMEPRODINE phenyl­4­propionoxypiperidine).

ALPHAMETHADOL diphenyl­3­heptanol).

ALPHAPRODINE (α­1,3­dimethyl­4­phenyl­4­propi­ onoxy­piperidine).

ANILERIDINE phenylpiperidine­4­carboxylic acid ethyl ester).
BENZETHIDINE phenylpiperidine­4­carboxylic acid ethyl ester).

BENZYLMORPHINE (3­benzylmorphine).

BETACETYLMETHADOL (β­3­acetoxy­6­dimethy­ lamino­4,4­diphenylheptane).

BETAMEPRODINE (β­3­ethyl­1­methyl­4­phenyl­4­ propionoxypiperidine).
(1­(2­benzyloxyethyl)­4­ (α­6­dimethylamino­4,4­ (α­3­ethyl­1­methyl­4­ ­aminophenethyl­4­ (1­para • • • • • • • 86 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 Schedule 2 3—continued • • • • • • • • • • • • • • • • (2­para ­chlorbenzyl­1­diethy­ (β­6­dimethylamino­4,4­ (β­1,3­dimethyl­4­phenyl­4­propi­ (dihydrocodeinone­6­carboxymethy­ BETAMETHADOL diphenyl­3­heptanol).

BETAPRODINE onoxypiperidine).


BEZITRAMIDE (1­(3­cyano­3,3­diphenylpropyl)­4­ (2­oxo­3­propionyl­1­benzimidazolinyl) piperidine).

CLONITAZENE laminoethyl­5­nitrobenzimidazole).

CODOXIME loxime).

CONCENTRATE OF POPPY STRAW—that is, the material arising when parts of any plant of the species Papaver somniferum have entered a process for the concentration of the alkaloids.

DEXTROMORAMIDE ((+)­4­[2­methyl­4­oxo­3,3­ diphenyl­4­(1­pyrrolidinyl) butyl] morpholine).
DIAMPROMIDE (N ­[2­(methylphenethylamino) propyl] propionanilide).

DIETHYLTHIAMBUTENE (3­diethylamino­1,1­di­ (2’­thienyl)­1­butene).

DIFENOXIN (1­(3­cyano­3, 3 diphenylpropyl)­4­ phenylisonipecotic acid).

DIHYDROMORPHINE.

DIMENOXADOL (2­dimethylaminoethyl 1­ethoxy­1, 1­diphenylacetate.)

DIMEPHEPTANOL diphenyl­3­heptanol).

DIMETHYLTHIAMBUTENE (3­dimethylamino­1,1­ di­(2’­thienyl)­1­butene).

DIOXAPHETYL BUTYRATE (ethyl 4­morpholino­2, 2­diphenylbutyrate).
DIPHENOXYLATE propyl)­4­phenylpiperidine­4­carboxylic ester).

(1­(3­cyano­3,3­diphenyl­ ethyl (6­dimethylamino­4,4­ acid 87 Schedule 2 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 3—continued (3­ethylmethy­ (1­diethylaminoethyl­2­para (1­phenethyl­4­(N­propiony­ (1­[2­(2­hydroxyethoxy)ethyl]­4­ (4,4­diphenyl­6­piperidine­3­hep­ (3,4­dimethoxy­17­methylmorphi­ DIPIPANONE tanone).

DROTEBANOL nan­6β, 14­diol).


EGGONINE, its esters and derivatives which are convertible to ecgonine and cocaine, except when contained in a Class C controlled drug.

ETHYLMETHYLTHIAMBUTENE lamino­1,1­di­(2’­thienyl)­1­butene).

ETONITAZENE ­ethoxybenzyl­5­nitrobenzimidazole).

ETOXERIDINE phenylpiperidine­4­carboxylic acid ethyl ester).

FENTANYL lanilino)piperidine).

p­FLUOROFENTANYL (4’­ﬂuoro­N­1­(phenethyl­4­ piperidyl) propionanilide).
FURETHIDINE (1­(2­tetrahydrofurfuryloxyethyl)­4­ phenylpiperidine­4­carboxylic acid ethyl ester).

HYDROCODONE (dihydrocodeinone).

HYDROMORPHINOL phine).

HYDROMORPHONE (dihydromorphinone).

β­HYDROXYFENTANYL yphenethyl)­4­piperidyl] propionanilide).

β­HYDROXY­3­METHYLFENTANYL (N­[1­(β­hy­ droxyphenethyl)­3­methyl­4­piperidyl] propio­ nanilide).

HYDROXYPETHIDINE (4­meta ­hydroxyphenyl­1­ methylpiperidine­4­carboxylic acid ethyl ester).

ISOMETHADONE (6­dimethylamino­5­methyl­4,4­ diphenyl­3­hexanone).
LEVOMETHORPHAN morphinan) but not ((−)­3­methoxy­N­methyl­ including dextromethorphan (14­hydroxydihydromor­ (N­[1­(β­hydrox­ • • • • • • • • • • • • • • • • • 88 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 Schedule 2 3—continued • • • • • • • • • • • • • • • • • (4­cyano­2­ ((−)­3­hydroxy­N ((−)­4­[2­methyl­4­oxo­3,3­ (6­dimethylamino­4,4­diphenyl­3­ ((+)­3­methoxy­N­methylmorphinan) and dextrorphan ((+)­3­hydroxy­N­methylmorphinan).

LEVOMORAMIDE diphenyl­4­(1­pyrrolidinyl)butyl] morpholine).
LEVOPHENACYLMORPHAN ­phenacylmorphinan).

LEVORPHANOL ((−)­3­hydroxy­N­methylmorphi­ nan).

MECLOQUALONE (3­(2­chlorophenyl)­2­methyl­4­ (3H)­quinazolinone).

** METAZOCINE (2’­hydroxy­2,5,9­trimethyl­6,7­ben­ zomorphan).

METHADONE heptanone).

METHADONE­INTERMEDIATE dimethylamino­4,4­diphenylbutane).

1­METHYL­4­PHENYL­4­PIPERIDINOL.

METHYLDESORPHINE phine).

METHYLDIHYDROMORPHINE (6­methyldihydro­ morphine).

α­METHYLFENTANYL methylphenethyl)­4­piperidyl] propionanilide).
α­METHYLTHIOFENTANYL (N­[1­[1­methyl­2­(2­ thienyl)ethyl]­4­piperidyl] propionanilide).

3­METHYLFENTANYL (N­[3­methyl­1­phenethyl­4­ piperidyl] propionanilide).

3­METHYLTHIOFENTANYL (N­[3­methyl­1­[2­(2­ thienyl)ethyl]­4­piperidyl]propionanilide).

METOPON (5­methyldihydromorphinone).

MORAMIDE­INTERMEDIATE pholino­1,1­diphenyl­propanecarboxylic acid).

MORPHERIDINE phenylpiperidine­4­carboxylic acid ethyl ester).
(1­(2­morpholinoethyl)­4­ (6­methyl­Δ6­deoxymor­ (2­methyl­3­mor­ (N­[1­(α­ 89 Schedule 2 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 3—continued ­3­(1­1­dimethylhep­ (6­dimethylamino­4,4­ MORPHINE METHOBROMIDE and other pentava­ lent nitrogen morphine derivatives.

MORPHINE­N­OXIDE.

MPPP (1­methyl­4­phenyl­4­piperidinol propionate (ester)).

MYROPHINE (myristylbenzylmorphine).

NABILONE (trans tyl)­6,6a,7,8,10,10a­hexahydro­1­hydroxy­6, 6­dimethyl­9H­dibenzo[b,d] pyran­9­one).
*** NICOMORPHINE (3,6­dinicotinylmorphine).

NORACYMETHADOL (α­3­acetoxy­6­methylamino­ 4,4­diphenyl­heptane).

NORLEVORPHANOL ((−)­3­hydroxymorphinan).

NORMETHADONE diphenyl­3­hexanone).

NORMORPHINE (demethylmorphine).

NORPIPANONE anone).

OXYCODONE (14­hydroxydihydrocodeinone).

OXYMORPHONE (14­hydroxydihydromorphinone).

PEPAP (1­phenethyl­4­phenyl­4­piperidinol acetate (ester)).

PETHIDINE boxylic acid ethyl ester).

PETHIDINE­INTERMEDIATE­A methyl­4­phenylpiperidine).
PETHIDINE­INTERMEDIATE­B dine­4­carboxylic acid ethyl ester).

PETHIDINE­INTERMEDIATE­C phenylpiperidine­4­carboxylic acid).

PHENADOXONE (6­morpholino­4,4diphenyl­3­hep­ tanone).

PHENAMPROMIDE (N­(1­methyl­2­piperidinoethyl) propionanilide).
(1­methyl­4­phenylpiperidine­4­car­ (4,4­diphenyl­6­piperidino­3­hex­ (4­phenylpiperi­ (1­methyl­4­ (4­cyano­1­ • • • • • • • • • • • • • • • • • • • • 90 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 Schedule 2 3—continued • • • • • • • • • • • • • • • • • • • (3,4­dimethyl­2­phenylmor­ (2’­hydroxy­5,9­dimethyl­2­ (4­phenyl­1­(3­phenylamino­ (1,3­dimethyl­4­phenyl­4­propi­ (1­(3­cyano­3,3­diphenylpropyl)­4­ PHENAZOCINE phenethyl­6,7­benzomorphan).

PHENDIMETRAZINE pholine).


1­PHENETHYL­4­PHENYL­4­PIPERIDINOL.

PHENMETRAZINE (3­methyl­2­phenylmorpholine).

PHENOMORPHAN (3­hydroxy­N ­phenethylmorphi­ nan).

PHENOPERIDINE (1­(3­hydroxy­3­phenylpropyl)­4­ phenylpiperidine­4­carboxylic acid ethyl ester).

PIMINODINE propyl)piperidine­4­carboxylic acid ethyl ester).

PIRITRAMIDE (1­piperidino)piperidine­4­carboxylic acid amide).

PROHEPTAZINE onoxyazacycloheptane).

PROPERIDINE (1­methyl­4­phenylpiperidine­4­car­ boxylic acid isopropyl ester).
RACEMETHORPHAN ((±)­3­methoxy­N ­methyl­ morphinan).

RACEMORAMIDE 3­diphenyl­4­ (1­pyrrolidiny) butyl] morpholine).

RACEMORPHAN ((±)­3­hydroxy­N ­methylmorphi­ nan).

REMIFENTANIL (1­(2­methoxycarbornyl­ethyl)­4­ (phenylpropionyl­amino)­piperidine­4­carboxylic acid methyl ester).

SUFENTANIL thienyl)ethyl]­4­pipe­ridyl] propionanilide).

** THEBACON (acetyldihydrocodeinone).

THEBAINE.

THIOFENTANYL (N piperidyl]propionanilide).

TILIDINE ((±­ethyl phenyl­3­cyclo­hexene­1­carboxylate).
** (N­[4­(methoxymethyl)­1­[2­(2­ ­[1­[2­(2­thienyl)ethyl]­4­ ((±)­4­[2­methyl­4­oxo­3, ­2­(dimethylamino)­1­ trans 91 Schedule 3 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 3—continued • TRIMEPERIDINE (1,2,5­trimethyl­4­phenyl­4­propi­ onoxypiperidine).
the items relating Part 3 clause 1 was amended, as from 13 January 1988, by section 9(4) Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193) by in­ to “ACETYL­α­METHYLFENTANYL”; serting “p­FLUOROFENTANYL”; “β­HY­ “β­HYDROXYFENTANYL”; DROXY­3­METHYLFENTANYL”; “1­METHYL­4­PHENYL­4­PIPERIDI­ NOL”; α­METHYLTHIOFENTANYL”; “3­METHYLFENTANYL”; “METHYLTHIOFENTANYL; MPPP; PEPAP”; “1­PHENETHYL­4­PHENYL­4­PIPERIDINOL”; “REMIFENTANIL”; “THIOFENTANYL”.
“α­METHYLFENTANYL; 2 3 4 5 1 The isomers of the substances mentioned in this Part of this Schedule whenever the existence of such isomers is possible within the speciﬁc chemical designation.

The esters and ethers of the substances mentioned in this Part of this Schedule and the esters and ethers of the isomers men­ tioned in clause 2 of this Part of this Schedule whenever the existence of such esters or ethers is possible.
The salts of the substances mentioned in this Part of this Schedule and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3 of this Part of this Schedule.

Substances containing any proportion of a substance men­ tioned in clause 1, clause 2, clause 3 or clause 4 of this Part of this Schedule.

Schedule 3 Class C controlled drugs Section 2(1) Part 1 • CANNABIS FRUIT.
92 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 Schedule 3 Part 1—continued • • • • CANNABIS PLANT (whether fresh, dried, or other­ wise)—That is, any part of any plant of the genus Cannabis except a part from which all the resin has been extracted.

CANNABIS SEED.

CATHA EDULIS PLANT.

COCA LEAF—That is, the leaf of any plant of any species of the genus Erythroxylon, except a leaf from which all ecgonine, cocaine, and any other ecgonine alkaloids have been removed.
In Part 1 the words “(whether fresh, dried, or otherwise)” were substituted by section 8 Misuse of Drugs Amendment Act 1982 (1982 No 151).

In Part 1 the item “CATHA EDULIS PLANT” was inserted by clause 4 Misuse of Drugs Order 1981 (SR 1981/114).
2 3 4 The following substances: BZP (1­benzylpiperazine or A2 benzylpiperazine or N­ben­ zylpiperazine (1­benzyl­1,4­diazacyclohexane)) TFMPP (1­(3­triﬂuoromethylphenyl)piperazine or N­(3­tri­ ﬂuoromethylphenyl)piperazine) pFPP (1­(4­ﬂuorophenyl)piperazine) MeOPP (1­(4­methoxyphenyl)piperazine) mCPP 1­(3­chlorophenyl)piperazine) MBZP (1­methyl­4­benzylpiperazine).

Schedule 3 Part 1 clause 2: added, on 1 April 2008, by section 4 of the Misuse of Drugs (Classiﬁcation of BZP) Amendment Act 2008 (2008 No 5).
(1­(meta­chlorophenyl)piperazine) or The isomers of the substances mentioned in clause 2 whenever the existence of such isomers is possible within the speciﬁc chemical designation.

Schedule 3 Part 1 clause 3: added, on 1 April 2008, by section 4 of the Misuse of Drugs (Classiﬁcation of BZP) Amendment Act 2008 (2008 No 5).
The esters and ethers of the substances mentioned in clause 2 and the esters and the ethers of the isomers mentioned in 93 Schedule 3 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 Part 1—continued clause 3 whenever the existence of such esters or ethers is pos­ sible.

Schedule 3 Part 1 clause 4: added, on 1 April 2008, by section 4 of the Misuse of Drugs (Classiﬁcation of BZP) Amendment Act 2008 (2008 No 5).
The salts of the substances mentioned in clause 2 and the salts of the isomers, esters, and ethers mentioned in clause 3 or 4.

Schedule 3 Part 1 clause 5: added, on 1 April 2008, by section 4 of the Misuse of Drugs (Classiﬁcation of BZP) Amendment Act 2008 (2008 No 5).

Substances containing any proportion of a substance men­ tioned in clause 2, 3, 4, or 5.

Schedule 3 Part 1 clause 6: added, on 1 April 2008, by section 4 of the Misuse of Drugs (Classiﬁcation of BZP) Amendment Act 2008 (2008 No 5).
Part 2 its isomers, esters, and CODEINE (3­methylmorphine); ethers, if any; its salts, and the salts of its isomers, esters, or ethers, if any; and any substance, preparation or mixture containing any proportion of the said substance or of any such isomer, ester, ether, or salt, other than a preparation or mixture named or described in Part 6 of this Schedule.
DIHYDROCODEINE; its isomers, esters, and ethers, if any; its salts, and the salts of its isomers, esters, or ethers, if any; and any substance, preparation, or mixture containing any pro­ portion of the said substance or of any such isomer, ester, ether, or salt, other than a preparation or mixture named or described in Part 6 of this Schedule.
PROPOXYPHENE N­dimethylamino)­1, 2­diphenyl­3­methyl­2­propionoxybutane); isomers, esters, and ethers, if any; its salts and the salts of its if any; except in preparations isomers, esters, or ethers, of propoxyphene described in clause 5A of Part 5 of this Schedule.

(α­4 (N, its 5 6 • • • In Part 2 the item relating to “DIHYDROCODEINE” was inserted, as from 2 September 1996, by section 8(1) Misuse of Drugs Amendment Act 1996 (1996 No 133).
94 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 Schedule 3 Part 2—continued In Part 2 the item relating to “DIHYDROCODEINE” was amended, as from 15 Novem­ ber 2000, by section 10 Misuse of Drugs Amendment Act 2000 (2000 No 47) by sub­ stituting the expression “Part 6” for the expression “Part 4”.

In Part 2 the item “PROPOXYPHENE” was substituted by clause 2(1) Misuse of Drugs Order (No 2) 1984 (SR 1984/315).

Part 3 ACETYLDIHYDROCODEINE.


The following substances, namely: • • • • • ETHYLMORPHINE (3­ethylmorphine).

NICOCODINE (6­nicotinylcodeine).

NICODICODINE (6­nicotinyldihydrocodeine or nico­ tinic acid ester of dihydrocodeine.

NORCODEINE (N ­demethylcodeine).

PHOLCODINE (morpholinylethylmorphine).

PROPIRAM (N ­2­pyridylpropionamide).


­(1­methyl­2­piperidinoethyl)­N • • • In Part 3 clause 1 the item relating to “DIHYDROCODEINE”, was omitted, as from 2 September 1996, by section 8(2) Misuse of Drugs Amendment Act 1996 (1996 No 133).

The isomers of the substances mentioned in this Part of this Schedule whenever the existence of such isomers is possible within the speciﬁc chemical designation.
The esters and ethers of the substances mentioned in this Part of this Schedule and the esters and the ethers of the isomers mentioned in clause 2 of this Part of this Schedule whenever the existence of such esters or ethers is possible.

The salts of the substances mentioned in this Part of this Schedule and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3 of this Part of this Schedule.
95 1 2 3 4 Schedule 3 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 Part 3—continued Substances containing any proportion of a substance men­ tioned in clause 1, clause 2, clause 3, or clause 4 of this Part of this Schedule, other than a preparation or mixture named or described in Part 6 of this Schedule.
Preparations of pseudoephedrine, its salts, isomers, esters, and ethers (if any), and the salts of its isomers, esters, and ethers (if any), being preparations— (a) (b) in solid or liquid form; and containing not more than 60 mg of pseudoephedrine per dosage unit; and containing either a single ingredient or being in com­ bination with other pharmacologically active ingredi­ ents, being ingredients that are not named or described in Schedule 1 or 2 or in Parts 1, 2, 4, or 5 of this sched­ ule.
(c) Clause 6 was inserted, as from 15 October 2004, by clause 3(1) Misuse of Drugs (Classiﬁcation of Ephedrine and Pseudoephedrine) Order 2003 (SR 2003/354).

See clause 2 Misuse of Drugs (Classiﬁcation of Ephedrine and Pseudoephedrine) Order Commencement Order 2004 (SR 2004/316).

Part 4 5 6 1 The following substances, namely: • • (17­cyclopropylmethyl­7,8­di­ ­6­0­ ALLOBARBITAL (5,5­diallylbarbituric acid).

AMOBARBITAL (5­ethyl­5­(3­methylbutyl) barbi­ turic acid).
BUPRENORPHINE hydro­7­(1­hydroxy­1,2, methyl­6, 14­ethano­17­normorphine).

BUTALBITAL (5­allyl­5­isobutylbarbituric acid).

BUTOBARBITONE (5­butyl­5­ethylbarbituric acid).

CYCLOBARBITAL (5­(1­cyclohexen­1­yl)­5­ethyl­ barbituric acid).

GLUTETHIMIDE (2­ethyl­2­phenylglutarimide).

2­trimethylpropyl) • • • • • 96 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 Schedule 3 Part 4—continued • • • • • (5­allyl­5­neopentylbarbituric NEALBARBITONE acid).
PENTOBARBITAL (5­ethyl­5­(1­methylbutyl) barbi­ turic acid).

SECBUTABARBITAL (5­sec­butyl­5­ethylbarbituric acid).

SECOBARBITAL (5­allyl­5­(1­methylbutyl) barbi­ turic acid).

VINYLBITAL acid).

(5­(1­methylbutyl)­5­vinylbarbituric 2 3 4 5 In Part 4 the item “BUPRENORPHINE” was substituted by clause 2 Misuse of Drugs Order 1984 (SR 1984/101).
Part 4 clause 1 was amended, as from 2 September 1996, by section 8(3) Misuse of Drugs Amendment Act 1996 (1996 No 133) by inserting the items relating to “ALLOBARBITAL” ; “BUTALBITAL” ; “SECBUTABARBITAL” and “VINYLBITAL”.

The isomers of the substances mentioned in this Part of this Schedule whenever the existence of such isomers is possible within the speciﬁc chemical designation.
The esters and ethers of the substances mentioned in this Part of this Schedule and the esters and the ethers of the isomers mentioned in clause 2 of this Part of this Schedule whenever the existence of such esters or ethers is possible.

The salts of the substances mentioned in this Part of this Schedule and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3 of this Part of this Schedule.
Substances containing any proportion of a substance men­ tioned in clause 1, clause 2, clause 3, or clause 4 of this Part of this Schedule, except a mixture of a derivative of barbituric acid named or described in clause 1 of this Part of this Sched­ ule compounded with one or more other pharmacologically active ingredients not named or described in clause 1 of this Part of this Schedule.
97 Schedule 3 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 Part 4—continued In Part 4 clause 5 was amended by clause 2(1) Misuse of Drugs Amendment Order 1978 (SR 1987/143).

1 Part 5 The following substances, namely: • • • • • • • • • • • • • • • • • • ALPRAZOLAM.

AMFEPRAMONE (2­(diethylamino) propiophenone).

AMINOREX.

BARBITAL (5,5­diethylbarbituric acid).

BROMAZEPAM.

BROTIZOLAM.

CAMAZEPAM.

CHLORDIAZEPOXIDE.

CLOBAZAM.

CLONAZEPAM.

CLORAZEPATE.

CLOTIAZEPAM.

CLOXAZOLAM.

DELORAZEPAM.


DIAZEPAM.

EPHEDRINE.

ESTAZOLAM.

ETHCHLORVYNOL carbinol).

ETHINAMATE (1­ethynylcyclohexanol carbamate).

ETHYL LOFLAZEPATE.

FLUDIAZEPAM.

FLUNITRAZEPAM.

FLURAZEPAM.

HALAZEPAM.

HALOXAZOLAM.

KETAZOLAM.


(ethyl­2­chlorovinylethynyl­ • • • • • • • • 98 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 Schedule 3 Part 5—continued (5­ethyl­1­methyl­5­ (3,3­diethyl­5­methylpiperi­ • • • • • • • • • • • • • • • • • • • • • (2­methyl­2­propyl­1,3­propane­ LOPRAZOLAM.

LORAZEPAM.

LORMETAZEPAM.

MAZINDOL (5­(4­chlorophenyl)­2, 5­dihydro­3H­im­ idazo [2, 1­a]­isoindol­5­ol).

MEDAZEPAM.

MEPROBAMATE diol dicarbamate).


METHYLPHENOBARBITAL phenylbarbituric acid).

METHYLPRYLON dine­2,4­dione).

MIDAZOLAM.

NIMETAZEPAM.

NITRAZEPAM.

NORDAZEPAM.

OXAZEPAM.

OXAZOLAM.

PEMOLINE.

PHENOBARBITAL (5­ethyl­5­phenylbarbituric acid).

PHENTERMINE (2­amino­2­methyl­1­phenyl­ propane).

PINAZEPAM.

PIPRADROL (1,1­diphenyl­1­(2­piperidyl)methanol).

PRAZEPAM.

PSEUDOEPHEDRINE (other than a preparation re­ ferred to in clause 6 of Part 3 of this schedule).
SPA ((−)­1­dimethylamino­1,2­diphenylethane).

TEMAZEPAM.

TETRAZEPAM.

TRIAZOLAM.

• • • • Part 5 clause 1: the item “MAZINDOL” was substituted by clause 2(2) Misuse of Drugs Order (No 2) 1984 (SR 1984/315), and the word “PHENTERMINE” was inserted by regulation 2(2) Misuse of Drugs Order 1982 (SR 1982/259).
99 Schedule 3 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 Part 5—continued “DIAZEPAM”, “ALPRAZOLAM”, “DELORAZEPAM”, Part 5 clause 1 was amended, as from 1 January 1999, by clause 2 Misuse of Drugs Order 1998 (SR 1998/351) by inserting items relating “BROMAZEPAM”, “BROTIZOLAM”, to: “CAMAZEPAM”, “CLOBAZAM”, “CHLORDIAZEPOXIDE”, “CLONAZEPAM”, “CLORAZEPATE”, “CLOTIAZEPAM”, “CLOX­ AZOLAM”, “ESTAZOLAM”, “ETHYL LOFLAZEPATE”, “FLUDIAZEPAM”, “FLUNITRAZEPAM”, “FLURAZEPAM”, “HALAZEPAM”, “HALOXAZOLAM”, “KETAZO­ LAM”, “LOPRAZOLAM”, “LORAZEPAM”, “LORMETAZEPAM”, “MEDAZEPAM”, “NI­ TRAZEPAM”, “NORDAZEPAM”, “OXAZEPAM”, “OXAZOLAM”, “PINAZEPAM”, “PRAZEPAM”, “TEMAZEPAM”, “TETRAZEPAM”, “TRIAZOLAM”.
Part 5 clause 1 was amended, as from 30 May 2003, by clause 6 Misuse of Drugs (Changes to Controlled Drugs) Order 2003 (SR 2003/47) by inserting items relating to “AMINOREX” and “PEMOLINE”.

See clause 2 Misuse of Drugs (Changes to Controlled Drugs) Order Commencement Order 2003 (SR 2003/116).
“NIMETAZEPAM”, “MIDAZOLAM”, Part 5 clause 1 was amended, as from 15 October 2004, by clause 3(2) Misuse of Drugs (Classiﬁcation of Ephedrine and Pseudoephedrine) Order 2003 (SR 2003/354) by inserting in their appropriate alphabetical order items relating to: “EPHEDRINE” and “PSEUDOEPHEDRINE (other than a preparation referred to in clause 6 of Part 3 of this schedule)”.

See clause 2 Misuse of Drugs (Classiﬁcation of Ephedrine and Pseudoephedrine) Order Commencement Order 2004 (SR 2004/316).
The isomers of the substances mentioned in this Part of this Schedule whenever the existence of such isomers is possible within the speciﬁc chemical designation.

The esters and ethers of the substances mentioned in this Part of this Schedule and the esters and the ethers of the isomers mentioned in clause 2 of this Part of this Schedule whenever the existence of such esters or ethers is possible.
The salts of the substances mentioned in this Part of this Schedule and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3 of this Part of this Schedule.

Mixtures of a derivative of barbituric acid named or described in Part 4 of this Schedule compounded with one or more other 2 3 4 5 100 5A 6 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 Schedule 3 Part 5—continued pharmacologically active ingredients not named or described in Part 4 of this Schedule.
In Part 5 clause 5 was repealed and cls 5 and 6 were substituted by regulation 2(2) Misuse of Drugs Order 1978 (SR 1978/143).
Preparations of propoxyphene, its isomers, esters, and ethers, if any, its salts, and the salts of its isomers, esters, or ethers, if any, for oral use containing not more than the equivalent of 135 milligrams of propoxyphene base per dosage unit or with a concentration of not more than 2.5 percent in undivided prep­ arations, being preparations whereof none of the other ingre­ dients is a substance named or described in Schedules 1 or 2 to this Act or in Parts 1 to 5 of this Schedule.
In Part 5 clause 5A was substituted by clause 2(3) Misuse of Drugs Order (No 2) 1984 (SR 1984/315).

Substances containing any proportion of a substance men­ tioned in clause 1, clause 2, clause 3, clause 4, clause 5 or clause 5A of this Part of this Schedule, other than a prepar­ ation or mixture named or described in Part 6 of this Schedule.

In Part 5 clause 5 was repealed and cls 5 and 6 were substituted by regulation 2(2) Misuse of Drugs Order 1978 (SR 1978/143).
In Part 5 clause 6 was amended by clause 2(4) Misuse of Drugs Order 1982 (SR 1982/259) by substituting the words “clause 5 or clause 5A” for the words “or clause 5”.
Part 6 The following substances, namely: (a) Preparations containing any proportion of the following substances or of any salt of any such substance, namely, acetyldihydrocodeine, codeine, dihydrocodeine, ethylmor­ phine, and pholcodine when: (i) Compounded with one or more other pharmacologi­ cally active ingredients in such a way that the substance cannot be recovered by readily applicable means or in a yield which would constitute a risk to health; and 101 Schedule 3 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 Part 6—continued (ii) Containing not more than 100 milligrams of the sub­ stance in each dosage unit and with a concentration of not more than 2.5 percent in undivided preparations: (c) (b) (d) (aa) Preparations containing a derivative of barbituric acid named or described in Part 4 or Part 5 of this Schedule, in solutions containing not more than 0.5 percent of that derivative of bar­ bituric acid: Preparations of cocaine containing not more than 0.1 percent of cocaine base, being preparations compounded with one or more other pharmacologically active ingredients (none of which are substances named or described in Schedules 1 or 2 to this Act or in Parts 1 to 5 of this Schedule ) in such a way that the preparation has no, or a negligible, risk of abuse, and in such a way that the cocaine cannot be recovered by readily applicable means or in a yield which would constitute a risk to health: Preparations of difenoxin containing, per dosage unit, not more than 0.5mg of difenoxin and a quantity of atropine sul­ phate equivalent to at least 5 percent of the dose of difenoxin: Preparations of opium or morphine containing not more than 0.2 percent of morphine, being preparations compounded with one or more other pharmacologically active ingredients (none of which are substances named or described in Schedules 1 or 2 to this Act or in Parts 1 to 5 of this Schedule ) in such a way that the opium or the morphine, as the case may be, cannot be recovered by readily applicable means or in a yield which
 would constitute a risk to health: Single dosage units of diphenoxylate containing in each unit not more than 2.5 milligrams of diphenoxylate calculated as base and not less than 25 micrograms of atropine sulphate: Liquid preparations of diphenoxylate containing, in each millilitre, not more than 0.5 milligrams of diphenoxylate calculated as base and not less than 5 micrograms of atroprine sulphate: Preparations of propiram containing not more than 100 mg of propiram per dosage unit and compounded with at least the same amount of methylcellulose: (ff) (e) (f) 102 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 Schedule 3 Part 6—continued (g) Ipecacuanha and opium powder containing 10 percent of opium in powder and 10 percent of ipecacuanha root in powder intimately mixed with ﬁnely powdered lactose: (h) Mixtures containing not more than one of the preparations spe­ ciﬁed in paragraphs (a) to (g) of this Part of this Schedule, being mixtures whereof none of the other ingredients is a sub­ stance named or described in Schedules 1 or 2 to this Act or in Parts 1 to 5 of this Schedule.
In Part 6 paras (aa) and (ff) were inserted by clause 2(3) and (4) Misuse of Drugs Order 1978 (SR 1978/143).

Part 7 Part 7 was inserted, as from 13 January 1988, by section 10 Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 170).
AMPHETAMINE ANALOGUES, in which the 1­amino­2­ phenylethane nucleus carries any of the following radicals, ei­ ther alone or in combination: (a) 1 or 2 alkyl radicals, each with up to 6 carbon atoms, attached to the nitrogen atom: 1 or 2 methyl radicals, or an ethyl radical, attached to the car­ bon atom adjacent to the nitrogen atom: A hydroxy radical, attached to the carbon atom adjacent to the benzene ring: (b) (c) (d) Any combination of up to 5 alkyl radicals and/or alkoxy radicals and/or alkylamino radicals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals and/or nitro radicals and/or amino radicals, attached to the benzene ring.
PETHIDINE ANALOGUES, in which a 4­phenylpiperidine nucleus carries any of the following radicals, either alone or in combination: An alkyl radical, with up to 6 carbon atoms, attached to the (a) nitrogen atom: (b) A phenalkyl radical, with up to 12 carbon atoms, attached to (c) the nitrogen atom: A phenalkyl radical, as in paragraph (b), with 1 or more alkyl radicals, each with up to 6 carbon atoms, attached to the ben­ zene ring in the phenalkyl radical: 103 Schedule 3 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 Part 7—continued (e) (d) An alkylcarbonyloxy or alkoxycarbonyl or hydroxy radical, with up to 6 carbon atoms, attached to the 4 position in the piperidine ring: Any combination of up to 5 alkyl radicals and/or alkoxy radi­ cals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals, attached to the benzene ring.
PHENCYCLIDINE ANALOGUES, being chemical compounds with the 1­alkylamino­1­arylcyclohexane structure, with any com­ bination of the following alkylamino and aryl radicals: (a) The alkylamino radical is 1­piperidinyl, 1­pyrrolidinyl, 4­mor­ pholinyl, or any other radical with up to 6 carbon atoms in the alkyl portion: The aryl radical is phenyl, thienyl, pyridinyl, or pyrrolidinyl: The aryl radical, as described in paragraph (b), carries any combination of up to 5 alkyl radicals and/or alkoxy radicals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals.
(b) (c) FENTANYL ANALOGUES, in which the N­[1­(2­phenethyl)­4­ piperidyl]aniline nucleus has additional radicals, either alone or in combination, attached as follows: (a) An acetyl, propionyl, butenoyl or butanoyl radical, attached to the aniline nitrogen atom: (b) One or more alkyl radicals, with up to 10 carbon atoms in total, (c) attached to the ethyl moeity: Any combination of up to 5 alkyl radicals and/or alkoxy radi­ cals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals, attached to each of the benzene rings.
in which the 3­arylquina­ METHAQUALONE ANALOGUES, zolin­4­one nucleus has additional radicals, either alone or in combination, attached as follows: (a) An alkyl radical, with up to 6 carbon atoms, attached at the two position: (b) Any combination of up to 5 alkyl radicals and/or alkoxy radi­ cals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals, attached to each of the aryl rings.
104 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 Schedule 4 Part 7—continued (b) DMT (DIMETHYLTRYPTAMINE) ANALOGUES, in which the 3­(2­aminoethyl)indole nucleus has additional radicals, either alone or in combination, attached as follows: (a) 1 or 2 alkyl radicals, each with up to 6 carbon atoms, including cyclic radicals, attached to the amino nitrogen atom: 1 or 2 methyl groups, or an ethyl group, attached to the carbon atom adjacent to the amino nitrogen atom: Any combination of up to 5 alkyl radicals and/or alkoxy radi­ cals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals, attached to the benzene ring.
In Part 7 paragraph (c) of the item relating to “FENTANYL ANALOGUES” was amended, as from 2 September 1996, by section 8(4) Misuse of Drugs Amendment Act 1996 (1996 No 133) by inserting the words “and/or halogen radicals,”.

(c) Schedule 4 Precursor Substances Section 2(1) Schedule 4 was inserted, as from 12 May 1998, by section 12 Misuse of Drugs Amendment Act 1998 (1998 No 14).
1 1 The following substances: • • • • • • • • ACETIC ANHYDRIDE N­ACETYLANTHRANILIC ACID EPHEDRINE ERGOMETRINE ERGOTAMINE ISOSAFROLE LYSERGIC ACID 3, PROPANONE 1­PHENYL­2­PROPANONE PIPERONAL POTASSIUM PERMANGANATE • • • 4,­METHYLENEDIOXYPHENYL­2 105 2 1 2 Schedule 4 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 1—continued PSEUDOEPHEDRINE SAFROLE • • ACETIC ANHYDRIDE and POTASSIUM PERMANGANATE: these items were inserted, as from 22 June 2005, by section 21(a) Misuse of Drugs Amend­ ment Act 2005 (2005 No 81).
The salts of the substances listed in clause 1 whenever the existence of such salts is possible.

2 ACETONE ANTHRANILIC ACID ETHYL ETHER HYDROCHLORIC ACID METHYL ETHYL KETONE PHENYLACETIC ACID PIPERIDINE The following substances: • • • • • • • • • • • ACETIC ANHYDRIDE and POTASSIUM PERMANGANATE: these items were omitted, as from 22 June 2005, by section 21(b) Misuse of Drugs Amend­ ment Act 2005 (2005 No 81).
SULPHURIC ACID TOLUENE The salts of the substances listed in clause 1 (other than the salts of hydrochloric acid and of sulphuric acid) whenever the existence of such salts is possible.

Part 3 was inserted, as from 22 June 2005, by section 20 Misuse of Drugs Amendment Act 2005 (2005 No 81).
3 106 1 2 1 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 Schedule 5 3—continued The following substances: EPHEDRINE • PSEUDOEPHEDRINE • The salts of the substances listed in clause 1 whenever the existence of such salts is possible.

Schedule 5 Amount, level, or quantity at and over which controlled drugs are presumed to be for supply ss 2(1A), 6(1)(f) Schedule 5 was inserted, as from 22 June 2005, by section 22 Misuse of Drugs Amendment Act 2005 (2005 No 81).
The controlled drugs listed in the ﬁrst column are presumed to be for supply at and over the amount, level, or quantity listed in the second column.
Am­ phetamine Morphine Cocaine Heroin 5 grams or 100 ﬂakes, tablets, capsules, or other drug forms each containing some quantity of the drug 5 grams, whether or not contained in a substance, preparation, or mixture half a gram, whether or not contained in a substance, preparation, or mixture half a gram, whether or not contained in a substance, preparation, or mixture Lysergide 2 and a half milligrams or 25 ﬂakes, tablets, capsules, or other drug forms each containing some quantity of the drug 107 Schedule 5 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 100 milligrams or 25 ﬂakes, tablets, capsules, or other drug forms each containing some quantity of the drug 5 grams or 100 ﬂakes, tablets, capsules, or other drug forms each containing some quantity of the drug 5 grams or 100 ﬂakes, tablets, capsules, or other drug forms each containing some quantity of the drug 5 grams or 100 ﬂakes, tablets, capsules, or other drug forms each containing some quantity of the drug 250 milligrams, whether or not contained in a substance, preparation, or mixture 5 grams or 100 cigarettes containing the drug 28 grams or 100 cigarettes containing the drug DOB (2­amino­l­ (4­ bromo­2.5­ dimethoxyphenyl) propane) (also known as bromo­ DMA) MDMA (2­methy­ lamino­1­ (3,4­ methylene­ dioxyphenyl) propane) N­ETHYL MDA (2­ethy­ lamino­l­ (3,4­ methylene­ dioxyphenyl) propane) MDA (2­amino­l­ (3,4­ methylene­ dioxyphenyl) propane) Tetrahydro­ cannabinol (as described in Schedule 2) Any cannabis preparation (as described in Schedule 2) Cannabis plant (as described in Schedule 3) 108 Misuse of Drugs Act 1975 Schedule 5 5 grams or 100 ﬂakes, tablets, capsules, or other drug forms each containing some quantity of the drug Reprinted as at 1 April 2008 BZP (1­ben­ zylpiper­ azine or A2 benzylpiper­ azine or N­ben­ zylpiper­ azine (1­ben­ zyl­1,4­di­ azacyclohex­ ane)) 5 grams or 100 ﬂakes, tablets, capsules, or other drug forms each containing some quantity of the drug TFMPP (1­(3­triﬂuo­ romethylphenyl)piper­ azine or N­(3­triﬂuo­
 romethylphenyl)piper­ azine) pFPP (1­(4­ﬂuo­ rophenyl)piper­ azine) 5 grams or 100 ﬂakes, tablets, capsules, or other drug forms each containing some quantity of the drug MeOPP (1­(4­ methoxyphenyl)piper­ azine) 5 grams or 100 ﬂakes, tablets, capsules, or other drug forms each containing some quantity of the drug 5 grams or 100 ﬂakes, tablets, capsules, or other drug forms each containing some quantity of the drug mCPP (1­(meta­ chlorophenyl)piper­ azine) or 1­(3­ chlorophenyl)piper­ azine) MBZP (1­methyl­4­ benzylpiper­ azine) 5 grams or 100 ﬂakes, tablets, capsules, or other drug forms each containing some quantity of the drug Metham­ phetamine 5 grams, whether or not contained in a substance, preparation, or mixture Schedule 5 clause 1: amended, on 1 April 2008, by section 5 of the Misuse of Drugs (Classiﬁcation of BZP) Amendment Act 2008 (2008 No 5).
Schedule 5 clause 1 was amended, as from 9 September 2005, by clause 4 Misuse of Drugs (Presumption of Supply­Amphetamine) Order 2005 SR 2005/174) by inserting the item “Amphetamine”.

See clause 2 Misuse of Drugs (Presumption of Supply­Amphetamine) Order Commencement Order 2005 (SR 2005/230).

109 Schedule 5 Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 2 Any controlled drug not speciﬁed in clause 1 is presumed to be for supply at and over the level of 56 grams.
110 Reprinted as at 1 April 2008 Misuse of Drugs Act 1975 Misuse of Drugs (Classiﬁcation of BZP) Amendment Act 2008 Public Act Date of assent Commencement 2008 No 5 14 March 2008 see section 2 1 2 6 Title This Act is the Misuse of Drugs (Classiﬁcation of BZP) Amendment Act 2008.

Commencement This Act comes into force on 1 April 2008.
Part 1 Amendments to principal Act and amnesty provision Amnesty provision Amnesty in relation to use and possession for personal use of BZP (1) Despite section 4 of this Act and section 7 of the principal Act, it is not an offence for a person, in relation to any of the controlled drugs added by section 4 of this Act to Part 1 of Schedule 3 of the principal Act, to do either or both of the following before 1 October 2008: (a) to possess for his or her own use an amount of that con­ trolled drug that is less than the amount, level, or quan­ tity at and over which that controlled drug is presumed to be for supply, as speciﬁed in Schedule 5 of the prin­ cipal Act (as amended by section 5 of this Act): to use that controlled drug.
(b) This section is subject to section 6 of the principal Act and to section 5 of this Act.

This section expires at the close of 30 September 2008.

(2) (3) 111 Notes Misuse of Drugs Act 1975 Reprinted as at 1 April 2008 Contents 1 2 3 General About this eprint List of amendments incorporated in this eprint (most recent ﬁrst) General This is an eprint of the Misuse of Drugs Act 1975.

It incorporates all the amendments to the Misuse of Drugs Act 1975 as at 1 April 2008.
The list of amendments at the end of these notes speciﬁes all the amendments incorporated into this eprint since 3 September 2007.

Relevant provisions of any amending enactments that contain transitional, savings, or application provisions are also included, after the Principal enactment, in chronological order.

About this eprint This eprint has not been ofﬁcialised.
For more information about ofﬁcialisation, please see "Making online legislation ofﬁcial" under "Status of legislation on this site" in the About section of this website.

List of amendments incorporated in this eprint (most recent ﬁrst) Misuse of Drugs Amendment Act 2008 (2008 No 13) Misuse of Drugs (Classiﬁcation of BZP) Amendment Act 2008 (2008 No 5) Notes 1 2 3 112